cis-Regulation in the Mammalian Rod Photoreceptor by Kwasnieski, Jamie C
Washington University in St. Louis
Washington University Open Scholarship
All Theses and Dissertations (ETDs)
Spring 3-4-2014
cis-Regulation in the Mammalian Rod
Photoreceptor
Jamie C. Kwasnieski
Washington University in St. Louis
Follow this and additional works at: https://openscholarship.wustl.edu/etd
This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has been accepted for inclusion in All
Theses and Dissertations (ETDs) by an authorized administrator of Washington University Open Scholarship. For more information, please contact
digital@wumail.wustl.edu.
Recommended Citation
Kwasnieski, Jamie C., "cis-Regulation in the Mammalian Rod Photoreceptor" (2014). All Theses and Dissertations (ETDs). 1244.
https://openscholarship.wustl.edu/etd/1244
WASHINGTON UNIVERSITY IN ST. LOUIS 
 
 
 
Division of Biology & Biomedical Sciences 
Molecular Genetics & Genomics 
 
 
 
Dissertation Examination Committee: 
Barak A. Cohen, Chair 
Joseph C. Corbo 
Joseph D. Dougherty 
James J. Havranek 
Robi D. Mitra 
Tim Schedl 
 
 
 
 
cis-Regulation in the Mammalian Rod Photoreceptor 
 
By 
 
Jamie C Kwasnieski 
 
 
 
A dissertation presented to the 
Graduate School of Arts and Sciences 
of Washington University in 
partial fulfillment of the 
requirements for the degree 
of Doctor of Philosophy 
 
 
 
May 2014 
St. Louis, Missouri 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ii 
TABLE OF CONTENTS 
LIST OF FIGURES ..................................................................................................................................... IV	  
LIST OF TABLES ........................................................................................................................................ V	  
ACKNOWLEDGEMENTS .......................................................................................................................... VI	  
ABSTRACT OF THE DISSERTATION .................................................................................................... VIII	  
CHAPTER 1: INTRODUCTION ................................................................................................................... 1	  
Gene Regulation Underlies Development and Cellular Response to Environment .............. 1	  
Regulation of Transcription ................................................................................................... 1	  
Properties of cis-Regulation .................................................................................................. 2	  
Developing Quantitative Models of Gene Expression ........................................................... 3	  
High Throughput Reporter Assay Development ................................................................... 5	  
cis-Regulation in the Mammalian Retina .............................................................................. 6	  
Scope of Thesis Work ........................................................................................................... 8	  
CHAPTER 2: COMPLEX EFFECTS OF NUCLEOTIDE VARIANTS IN A MAMMALIAN CIS-
REGULATORY ELEMENT ........................................................................................................................ 11	  
ABSTRACT ............................................................................................................................. 12	  
INTRODUCTION .................................................................................................................... 13	  
RESULTS ............................................................................................................................... 14	  
Analysis of Single Mutants .................................................................................................. 15	  
Binding Site Mutations ........................................................................................................ 16	  
Analysis of Double Mutant CRE Variants ........................................................................... 19	  
DISCUSSION .......................................................................................................................... 19	  
ACKNOWLEDGEMENTS ....................................................................................................... 21	  
MATERIALS AND METHODS ................................................................................................ 22	  
CRE-seq Library Construction ............................................................................................ 22	  
Retinal Electroporation ........................................................................................................ 22	  
Comparison Between a Fluorescence Assay and CRE-seq ............................................... 23	  
Preparing Samples for RNA-Seq ........................................................................................ 23	  
Determination of Expression Levels of Rho Variants .......................................................... 24	  
Analysis of Binding Site Mutations ...................................................................................... 24	  
Non-additive Model for Variants with Two Substitutions ..................................................... 24	  
SUPPLEMENTARY FIGURES AND TABLES ........................................................................ 30	  
CHAPTER 3: COMBINATIONS OF CRX AND NRL BINDING SITES GENERATE DIVERSE 
EXPRESSION LEVELS ............................................................................................................................. 36	  
ABSTRACT ............................................................................................................................. 37	  
INTRODUCTION .................................................................................................................... 38	  
RESULTS ............................................................................................................................... 39	  
CRE-seq Library and Measurements .................................................................................. 39	  
Synthetic CREs Control Diverse Expression Levels ........................................................... 40	  
Patterns in Regulation by CRX and NRL ............................................................................ 41	  
Repression is Dependent on CRX ...................................................................................... 41	  
DISCUSSION .......................................................................................................................... 42	  
MATERIALS AND METHODS ................................................................................................ 45	  
Synthetic CRE Library Design ............................................................................................ 45	  
CRE-seq Library Construction ............................................................................................ 45	  
Retinal Electroporation ........................................................................................................ 46	  
SUPPLEMENTARY FIGURES AND TABLES ........................................................................ 52	  
CHAPTER 4: DISCUSSION ...................................................................................................................... 55	  
iii 
Comparison of Methods for High Throughput Reporter Analysis ....................................... 55	  
Potential Improvements to CRE-seq ................................................................................... 56	  
Phenotypic Interpretation of Mutagenesis Study ................................................................ 57	  
Complex Expression Controlled by Simple cis-Regulatory Elements ................................. 59	  
APPENDIX 1: MASSIVELY PARALLEL SYNTHETIC PROMOTER ASSAYS REVEAL THE IN VIVO 
EFFECTS OF BINDING SITE VARIANTS ................................................................................................ 60	  
ABSTRACT ............................................................................................................................. 61	  
INTRODUCTION .................................................................................................................... 62	  
RESULTS ............................................................................................................................... 63	  
Construction Of A Barcoded Synthetic Promoter Library .................................................... 63	  
CRE-Seq Accurately Measures Gene Expression .............................................................. 64	  
Model Selection .................................................................................................................. 65	  
The Thermodynamic Model Predicts In Vivo Relative Affinities Between Tfs and DNA ..... 67	  
Gcr1 Participates In Complex TF-TF Interactions ............................................................... 68	  
DISCUSSION .......................................................................................................................... 68	  
ACKNOWLEDGEMENTS ....................................................................................................... 69	  
MATERIALS AND METHODS ................................................................................................ 70	  
Construction of the CRE-BC Library ................................................................................... 70	  
Matching CREs to BCs ....................................................................................................... 70	  
Flow Cytometer Assay ........................................................................................................ 71	  
CRE-seq ............................................................................................................................. 71	  
Thermodynamic Model ....................................................................................................... 72	  
Outlier Detection ................................................................................................................. 73	  
PWM Analysis ..................................................................................................................... 74	  
SUPPLEMENTARY FIGURES AND TABLES ........................................................................ 82	  
APPENDIX 2: HIGH-THROUGHPUT FUNCTIONAL TESTING OF ENCODE SEGMENTATION 
PREDICTIONS .......................................................................................................................................... 89	  
ABSTRACT ............................................................................................................................. 90	  
INTRODUCTION .................................................................................................................... 91	  
RESULTS ............................................................................................................................... 91	  
CRE-seq Library and Measurements .................................................................................. 92	  
Expression of Segmentation Classes ................................................................................. 93	  
Sequence and Chromatin Features .................................................................................... 95	  
DISCUSSION .......................................................................................................................... 96	  
MATERIALS AND METHODS ................................................................................................ 98	  
CRE-seq Library Construction ............................................................................................ 98	  
Cell culture and Transfection .............................................................................................. 98	  
Selection of Segmentation Predictions ............................................................................... 99	  
Preparing Samples for RNA-Seq ........................................................................................ 99	  
Data sources ..................................................................................................................... 100	  
Logistic regression models ............................................................................................... 100	  
SUPPLEMENTARY FIGURES AND TABLES ...................................................................... 106	  
REFERENCES ........................................................................................................................................ 113	  
CURRICULUM VITAE ............................................................................................................................. 121	  
 
iv 
LIST OF FIGURES 
FIGURE 2.1 ................................................................................................................................................ 26 
FIGURE 2.2 ................................................................................................................................................ 27 
FIGURE 2.3 ................................................................................................................................................ 28 
FIGURE 2.4 ................................................................................................................................................ 29 
FIGURE 2.S1 ............................................................................................................................................. 31 
FIGURE 2.S2 ............................................................................................................................................. 32 
FIGURE 2.S3 ............................................................................................................................................. 33 
FIGURE 2.S4 ............................................................................................................................................. 34 
FIGURE 2.S5 ............................................................................................................................................. 35 
FIGURE 3.1 .................................................................................................................................................. 47 
FIGURE 3.2 .................................................................................................................................................. 48 
FIGURE 3.3 .................................................................................................................................................. 49 
FIGURE 3.4 .................................................................................................................................................. 50 
FIGURE 3.S1 ............................................................................................................................................... 53 
FIGURE 3.S2 ............................................................................................................................................... 54 
FIGURE A1.1 ............................................................................................................................................. 75 
FIGURE A1.2 ............................................................................................................................................. 76 
FIGURE A1.3 ............................................................................................................................................. 77 
FIGURE A1.4 ............................................................................................................................................. 78 
FIGURE A1.5 ............................................................................................................................................. 79 
FIGURE A1.S1 ........................................................................................................................................... 84 
FIGURE A1.S2 ........................................................................................................................................... 85 
FIGURE A1.S3 ........................................................................................................................................... 86 
FIGURE A1.S4 ........................................................................................................................................... 87 
FIGURE A1.S5 ........................................................................................................................................... 88 
FIGURE A2.1 ............................................................................................................................................. 102 
FIGURE A2.2 ............................................................................................................................................. 103 
FIGURE A2.3 ............................................................................................................................................. 104 
FIGURE A2.S1 ........................................................................................................................................... 108 
FIGURE A2.S2 ........................................................................................................................................... 109 
FIGURE A2.S3 ........................................................................................................................................... 110 
FIGURE A2.S4 ........................................................................................................................................... 111 
FIGURE A2.S5 ........................................................................................................................................... 112 
 
  
v 
 
LIST OF TABLES 
TABLE 3.1 .................................................................................................................................................... 51 
TABLE 3.S1 ................................................................................................................................................. 52 
TABLE A1.1 ............................................................................................................................................... 80 
TABLE A1.2 ............................................................................................................................................... 81 
TABLE A1.S1 ............................................................................................................................................. 82 
TABLE A1.S2 ............................................................................................................................................. 83 
TABLE A2.1 ............................................................................................................................................... 105 
TABLE A2.S1 ............................................................................................................................................. 106 
TABLE A2.S2 ............................................................................................................................................. 107 
 
vi 
ACKNOWLEDGEMENTS 
My thesis work would not have been possible without the support of many people. First, I would 
like to thank my advisor, Barak Cohen, for his guidance and encouragement. Without his mentorship, this 
work would not have been possible. I am grateful to have a mentor who sees the big picture, asks hard 
questions, and challenges me to take risks. Since joining the lab, Barak has taught me how to identify 
important questions, think about problems quantitatively and convey my thoughts clearly. Barak has 
cultivated a spirit of rigor and curiosity in the lab and it is truly a great place to learn.  
I would like to thank my thesis committee—Joe Corbo, Joe Dougherty, Jim Havranek, Rob Mitra, 
and Tim Schedl—for their advice and critical feedback, which has been crucial throughout my project. I 
am grateful to Melanie Relich and Margie Andersohn for their help with the administrative aspects of my 
graduate work.  
In particular, I would like to thank Joe Corbo and his lab for their close collaboration on this 
project. I am thankful for the opportunity to work in the mammalian retina; it has been a complex and 
interesting system for the study of transcriptional regulation. Joe’s passion and excitement has been 
critical in propelling this work forward. I would like to thank Connie Myers for helping me with the retinal 
experiments. Her hard work, patience, and attention to detail have made this study possible. I would also 
like to thank Susan Shen for her guidance and technical advice regarding retinal ChIP. 
I have enjoyed my time in the Cohen lab, and I cannot imagine training in a better environment. 
To Ilaria Mogno, thank you for being my partner throughout the development of CRE-seq. I appreciate 
your support, ideas, and persistence throughout the project. To Chris Fiore and Hemangi Chaudhari, it 
has been a pleasure working with you on the ENCODE project—your enthusiasm and excitement made 
the study possible. To Chris Fiore, thank you for your technical and emotional support. It has been 
wonderful to have such a close friend in the lab.  To Kim Lorenz, thank you for the emotional support, 
company during errands, proofreading help, and constant supply of chocolate. To Robert Zeigler, thank 
you for the R tutorials and the conversations about science. Your quantitative perspective has always 
challenged me and your passion for science is contagious. To Aaron Spivak, thank you for the technical 
advice regarding transcription factor binding. To Brett Maricque, thank you for being a patient and fun bay 
mate. To the other members of the Cohen lab: Priya Sudarsanam, Josh Witten, Linda Riles, Mike White, 
vii 
Marc Sherman, Dana King, Devi Swain, Amy Li, and Darcy Nayler, thank you for your scientific feedback 
and friendly conversations.  
I would like to thank the members of the CGS epigenetics journal club: Francesco Vallania, 
Maxim Schillebeeckx, Brett Maricque, Kate Chiappinelli, and Chris Fiore. The time we spent reading and 
discussing papers was valuable to my development as a scientist and challenged the way I thought about 
problems.  
I would like to thank all of my friends, those near and far, because without them, the hard parts of 
graduate school would have been even more difficult. Specifically, thanks to Marie Strand for helping me 
 ccare for my cat Simon and for her company.  
I cannot thank my parents enough for their support. Throughout my time in school they have 
made trips to St. Louis, sent me surprise packages, and helped me in ways I cannot even remember. I 
would especially like to thank Megan Falke, my sister and best friend. She has been an enthusiastic 
cheerleader and a reliable friend, even taking calls in the middle of the night to support me. I would like to 
thank my boyfriend’s family, for welcoming me into their life and being interested in my work.  
Most of all, I would like to thank my boyfriend, Ben Schriesheim, for his love and support. Ben has 
moved all the way from Boston to live with me in St. Louis. Having Ben in St Louis has made every day 
better because I have a partner for adventures and another cook in the kitchen, but especially because I 
can spend time with my best friend. 
 
This work was funded by NIH grants:  R01 RGM092910A, R21 HG006346-01, R01 HG006790-01, and 
T32 HG000045-15. 
 
  
viii 
 
ABSTRACT OF THE DISSERTATION 
cis-Regulation in the Mammalian Rod Photoreceptor 
By 
Jamie C Kwasnieski 
Doctor of Philosophy in Molecular Genetics and Genomics 
Washington University in St. Louis, 2014 
Professor Barak A. Cohen, Chair 
	  
Transcription factors regulate the expression level of target genes by binding to cis-regulatory 
elements (CREs) present in gene promoters. The goal of my thesis research is to define the sequence 
components of CREs that determine transcriptional output.  In order to accomplish this goal, I developed 
a method to measure the regulatory activity of thousands of CREs in a single experiment. In this method I 
insert unique barcodes in the 3’UTR of a reporter gene and multiplex expression measurements with 
RNA sequencing.  Using this technique in explanted retinas, I determined the impact of single nucleotide 
variants in a mammalian promoter by measuring expression controlled by all single nucleotide variants of 
the Rhodopsin proximal promoter.  I found that nearly all (86%) sequence variants drive significantly 
different activity than the wild-type promoter and that the mechanism of most variants can be interpreted 
as altered transcription factor binding.  In addition, we found that the largest changes in expression 
resulted from variants located in characterized transcription factor binding site sequences.  Next, I 
explored how combinations of binding sites drive particular levels of gene expression by utilizing a 
synthetic biology approach.  I generated synthetic CREs composed of various combinations of binding 
sites found in the Rhodopsin promoter and measured the expression driven by these sequences. In this 
study I found that synthetic CREs containing binding sites for transcriptional activators yielded diverse 
expression outputs, including both activation and repression of a minimal promoter. Together, these 
experiments demonstrate that interactions between binding sites and dual regulation of a single binding 
site can produce diverse gene expression patterns. I conclude that simple cis-regulatory elements can 
produce complex expression outputs due to interactions between transcriptional activators and detailed 
quantitative models will be necessary to predict expression from these sequences. 	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CHAPTER 1: INTRODUCTION 
 
Gene Regulation Underlies Development and Cellular Response to Environment 
Changes in gene expression control the process of cell differentiation. The development of an 
organism begins when an egg is fertilized to become a zygote. These cells grow, divide, and differentiate 
from a population of identical cells to an adult organism composed of tissue and organ systems with 
distinct cell identities. Directions describing the appropriate expression levels and patterns for each gene 
are encoded in the four base pair code of the organism’s genome and cells with distinct identities interpret 
these instructions differently.  
Changes in gene expression also allow cells to respond to environmental stimuli, as 
demonstrated in the work by Francois Jacob and Jacques Monod. Jacob and Monod showed that at any 
time, not all of an organism’s genes are expressed, and the regulation of gene levels is critical for a cell’s 
ability to adapt to a changing environment (Jacob and Monod 1961). In Escherichia coli, cells altered 
expression of genes when there was a change in sugar supply or bacteriophage infection and this cellular 
response could be de-coupled from the regulation of the response. This decoupling is due to the actions 
of a class of genes that regulate the expression of other genes. Since this discovery, the field of 
transcriptional regulation has studied how regulatory proteins manage expression levels.  
The expression level of a given gene can be controlled at many steps in the process: transcription 
initiation, RNA Polymerase II (RNA Pol II) elongation, mRNA transcript stability, translation efficiency, 
protein modification, and protein degradation. Of these steps, the regulation of transcription is most 
capable of generating diverse expression levels. Transcriptional regulation is critical for key biological 
processes. Understanding how this regulation is coordinated is an important step toward understanding 
cellular behavior, particularly during development and in response to environment. 
 
Regulation of Transcription 
Transcription factors (TFs) are proteins that regulate gene expression by binding to short specific 
DNA sequences called transcription factor binding sites (TFBS). Combinations of TFBS make up DNA 
sequences that modulate transcriptional regulation, like proximal promoter sequences or distal enhancer 
2 
elements. In particular, cis-regulatory elements (CREs) are sequences composed of TFBS that are 
located cis to gene bodies and control expression of the nearby gene. Transcriptional activators are TFs 
that promote recruitment of the RNA Pol II complex, whereas transcriptional repressors inhibit 
recruitment. TFs bind TFBS located within CREs, TFs recruit RNA Pol II machinery and set in motion a 
series of steps that begin transcription (Ptashne and Gann 1997; Ptashne 2005). The assembly of the 
RNA Pol II complex and subsequent transcription is well-described (Lee and Young 2000), but there are 
many outstanding questions about how and when transcription factors can recruit the RNA Pol II 
complex. Sequence features such as the number or affinity of a TFBS, can impact the control of gene 
expression (Yuh et al. 2001; Arnosti 2003; Rastegar et al. 2008) but it is not clear which patterns are 
important for gene activation. The major goal of this study is to understand the characteristics and 
sequence features that allow a CRE to control gene expression  
 
Properties of cis-Regulation 
There are several well-understood examples of cis-regulatory elements that illustrate how 
eukaryotic sequences are able to generate condition-specific gene expression levels. These examples 
often utilize combinatorial regulation by multiple TFs, cooperative TF binding, and competition between 
TFs to achieve condition or cell specific expression patterns. Three such examples are described.  
Combinations of TFs are important to integrate cellular signals. As an example, we can examine 
the regulation of the Saccharomyces cerevisae galactokinase gene GAL1 (Ptashne and Gann 2002), 
which is necessary for the metabolism of galactose. Yeast prefers glucose to galactose, so Gal1 is only 
expressed when galactose is the sole sugar in the media. Transcriptional activator Gal4 is constitutively 
bound to the upstream activating sequence (UAS) of the GAL1 gene. In the presence of glucose, the 
transcriptional repressor Gal80 inhibits RNA Pol II and represses the GAL1 gene. Upon sensing 
galactose, Gal80 repression is relieved and Gal4 is able to activate transcription of GAL1. If both glucose 
and galactose are present, the transcriptional repressor Mig1 represses transcription of GAL1. Thus, the 
GAL1 gene is expressed only in the presence of galactose through the activity of condition-specific 
transcriptional repressors. This example demonstrates that several TFs are necessary to integrate 
different signals, a common feature of eukaryotic regulatory elements (Remenyi et al. 2004).  
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Cooperative TF binding is often utilized to achieve switch-like behavior for a gene that needs to 
be quickly activated (Carey 1998; Vashee et al. 1998). The human Interferon-beta (IFN-beta) gene is 
usually silenced but is activated in the presence of viral infection. Regulation of this gene utilizes TF 
cooperativity to achieve this dynamic behavior (Merika and Thanos 2001). The inputs of three signaling 
pathways activate TFs that bind to three distinct enhancer sequences. Upon TF binding, the three 
enhancers loop to the promoter of the IFN-beta gene to activate transcription. All three enhancers are 
necessary for activation of the gene and TF binding within these enhancers is highly cooperative (Carey 
1998), allowing for robust activation of the gene.  
Competitive TF binding results when TFs with overlapping specificity are expressed in the same 
cell at the same time. In the case of regulation of the battery of genes necessary to maintain pluripotency, 
paralogous TFs POU5F1 and POU2F1 are co-expressed in the same cells and bind the same DNA 
sequences (Phillips and Luisi 2000). Genome-wide studies have found that POU5F1 achieves specificity 
by binding near TFBS for the co-regulator NANOG, whereas POU2F1 achieves specificity by binding 
nearby SOX2 TFBS (Ferraris et al. 2011). Competitive binding of paralogous TFs is a side effect of the 
co-expression of TFs with overlapping specificities and binding site specificity is achieved by 
combinatorial binding with co-regulators. 
Taken together, we learn that eukaryotic transcriptional regulation involves the integration of 
multiple TF binding events, cooperative TF binding, and competitive TF binding in order to generate 
expression patterns that have spatial and temporal specificity.  
 
Developing Quantitative Models of Gene Expression 
As these examples demonstrate, there is a general understanding of how transcription is 
regulated but the field lacks a quantitative model to describe how regulatory sequence controls gene 
expression level. It would be useful to predict the level of gene expression controlled by a particular 
sequence for two main reasons. First, this model would predict how gene expression levels are altered by 
sequence mutations, aiding in the interpretation of human genetic variation. Most of the variation in the 
human genome is located in non-coding regions of the genome (Abecasis et al. 2010). In fact, a large 
fraction of GWAS hits are found in non-coding sequence, suggesting that these polymorphisms have 
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phenotypic consequences (Kasowski et al. 2010; Maurano et al. 2012). In addition, we have little intuition 
for how these variants might impact gene expression of the individual. Second, this model would predict 
the expression controlled by novel regulatory sequences, allowing for engineering of synthetic cis-
regulatory sequences that drive a gene product at desired levels and patterns. The ability to engineer 
targeted gene expression levels would be useful in a variety of applications, including the development of 
gene therapies, the modification of agricultural crops, and the production of biofuels.  
In order to formulate such predictive models, a more detailed understanding of cis-regulatory 
sequences must be established. To start, it would be useful to understand how common sequence 
properties impact gene expression. Properties including binding site affinity (Tanay 2006), binding site 
combinations (Zinzen et al. 2009; Slattery et al. 2011; Rembold et al. 2014), and DNA shape (Parker et 
al. 2009) can effect gene expression control, in addition to genomic features like nucleosome occupancy 
(Polach and Widom 1996; Lam et al. 2008; Kaplan et al. 2009). Developing a quantitative model for a 
particular sequence would require manipulating the sequence a large number of times, cataloging the 
resulting expression, and developing a framework that fits this behavior.  
There exist several commonly used quantitative frameworks to predict expression from DNA 
sequence. Methods utilizing thermodynamic principles (Shea and Ackers 1985; Buchler et al. 2003; Segal 
et al. 2008; Gertz et al. 2009; Raveh-Sadka et al. 2009; Wasson and Hartemink 2009) generate 
parameter sets that represent biophysical interactions. Other approaches use linear regression 
(Bussemaker et al. 2001), dynamical equations (Goutsias and Kim 2004), Bayesian networks (Beer and 
Tavazoie 2004), stochastic models (Paulsson 2005) and hybrid methods (Setty et al. 2003). The choice of 
a particular model framework is made based on the available type of gene expression data. 
Regardless of the specified model framework, there generally does not exist enough to fit these 
models. The Encyclopedia of DNA Elements Consortium (ENCODE) was established to catalog all active 
regulatory elements in the human genome (Birney et al. 2007; Dunham et al. 2012). As part of the 
ENCODE dataset, several labs have measured RNA-seq for many cell types, but connecting these 
expression levels to the regulatory elements that are responsible for the expression remains a difficult 
task for scientists. Thus, these efforts have gathered large datasets but they are not systematic enough to 
be useful in training many of the previously mentioned quantitative models. This study focuses on the 
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development of high throughput assay development in order to make progress toward a more detailed 
quantitative model of gene expression.  
 
High Throughput Reporter Assay Development 
At the time I began my thesis work there were a variety of high-throughput techniques that could 
be used to identify mammalian sequences with regulatory potential. These techniques include methods to 
identify open chromatin with DNase Hypersensitivity sequencing (DNase-seq) or Formaldehyde-Assisted 
Isolation of Regulatory Element sequencing (FAIRE-seq) (Giresi et al. 2007; Boyle et al. 2008), methods 
to identify genomic regions where regulating TFs are bound by chromatin immunoprecipitation 
sequencing (ChIP-seq) (Solomon et al. 1988; Harbison et al. 2004; Johnson et al. 2007; Visel et al. 
2009), RNA sequencing (RNA-seq) methods to identify transcribed portions of the genome (Mortazavi et 
al. 2008; Nagalakshmi et al. 2008; Kim et al. 2010), and chromatin capture methods to identify distal 
sequences that are looped into core promoters (Dekker et al. 2002; Dostie et al. 2006). These 
technologies are widely used in the field to identify putative enhancers. Many groups have looked for 
patterns in this compendium of enhancers, but any identified TFBS patterns are based on correlation 
between sequence and expression, rather than a result of direct manipulation. Thus, there was a gap 
between our ability to generate putative enhancers and our ability to functionally test sequences for 
activity. 
Traditionally, reporter assay techniques have been used to determine if a DNA sequence has the 
ability to control expression of a downstream gene. In this approach, a putative cis-regulatory sequence is 
cloned upstream of a minimal promoter driving expression of a visualizable reporter gene, such as Green 
Fluorescent Protein gene or Firefly Luciferase gene. This DNA construct is transfected or electroporated 
into the tissue of interest and activity is determined by how much the CRE modifies expression of the 
minimal promoter. Reporter assay analysis allows direct functional testing of cis-regulatory function. 
Reporter assays are widely used, although the need for serial construction and testing makes this 
a low throughput technique that requires large amounts of cell material. Much time and effort is required 
to develop even a modest set of reporter genes, which are necessary for a simple experiment. For 
example, if one wanted to understand how sequence mutations impact the control of gene expression, 
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one might create a series of constructs, each with a single change in the wild type sequence. Even for a 
short 10 bp sequence, examining the three possible mutations at each position would require 30 DNA 
constructs, which is time intensive when utilizing a low throughput construction approach. In addition, the 
traditional assay would require at least 30 separate cell samples for serial assay, not including those 
necessary for biological replicates.  
Despite the amount of time it takes, several groups have used this strategy to develop large 
numbers of reporter genes (Chiang et al. 2006; Ligr et al. 2006; Cox et al. 2007; Kinney et al. 2007; 
Kinkhabwala and Guet 2008; Gertz and Cohen 2009; Gertz et al. 2009; Landolin et al. 2010; Schlabach 
et al. ; Yun et al. 2012). Some groups have attempted to improve throughput by employing randomized 
libraries, but because of the random nature of the construction, these techniques do not provide a 
systematic set of constructs. In order to gain a detailed understanding of how sequence characteristics 
affect gene expression control, expression comparisons of all sequence derivatives are necessary. 
Therefore a higher throughput reporter assay technique was needed.  
 
cis-Regulation in the Mammalian Retina 
There are three main reasons why the mammalian rod photoreceptor cell is useful system for the 
development of a high throughput reporter assay. First, the mammalian retina is an accessible tissue that 
allows for nearly homogeneous cell analyses. The mouse retina is readily dissectible and it is possible to 
electroporate transgenic DNA directly into the live or explanted retinas (Matsuda and Cepko 2004; Hsiau 
et al. 2007). The retina is composed of several distinct cell types, but 70% (Carter-Dawson and LaVail 
1979; Roorda and Williams 1999) of the cells in the mammalian retina are photoreceptors and roughly 
73% of photoreceptors are rod cells. We are able to measure gene expression from rod cells specifically 
because we electroporate transgenic DNA after other common cell types have completed mitosis, but 
before rod precursor cells finish dividing (Swaroop et al. 2010). By electroporating DNA into explanted 
retinas on postnatal day 0 and harvesting RNA at postnatal day 8, we are able to accomplish this.  
Second, the transcription factors that regulate rod cell differentiation and homeostasis are well 
characterized. Rod cell gene expression is controlled by three main factors: CRX, NRL, and Nr2e3. The 
cone/rod homeobox TF, CRX, specifies photoreceptor cell fate in the retina (Freund et al. 1997; 
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Furukawa et al. 1997; Furukawa et al. 1999; Hennig et al. 2008). CRX is a transcriptional activator (Chen 
et al. 1997), that may act by recruiting chromatin remodeling enzymes (Peng and Chen 2007). The neural 
leucine zipper transcriptional activator, NRL, is both necessary and sufficient for rod cell differentiation 
(Mears et al. 2001; Oh et al. 2007). The orphan nuclear receptor transcription factor Nr2e3 is a dual 
transcriptional regulator that is important for the repression of cone genes in rod cells (Kobayashi et al. 
1999; Chen et al. 2005; Peng et al. 2005; Webber et al. 2008). 
In addition, binding specificity (Kataoka et al. 1994; Chen et al. 2005; Montana et al. 2011b) and 
genomic binding preferences (Corbo et al. 2010; Hao et al. 2012) have been characterized for these 
factors, so we have a complete understanding of in vitro and in vivo binding preferences for these TFs. 
CRX, NRL and Nr2e3 have been shown to co-regulate at rod specific genes (Rehemtulla et al. 1996; 
Cheng et al. 2004; Peng et al. 2005), signifying that they are important for transcriptional control in the rod 
cell. In addition, other experiments have been done to characterize rod cell gene expression at the 
transcriptome level (Livesey et al. 2000; Blackshaw et al. 2001; Akimoto et al. 2006; Hsiau et al. 2007). 
These studies are useful because they provide a comprehensive view of expressed genes and other 
potential regulators. 
Third, we know that gene regulation in the mammalian retina has implications for human health. 
The Rhodopsin (Rho) gene is the most highly expressed gene in the mammalian retina; it allows rod 
photoreceptors to coordinate black/white and dim light vision. Rho dysregulation can result in retinal 
degeneration and subsequent vision loss (Humphries et al. 1997). In addition, mutations in known 
regulators CRX (Freund et al. 1997; Freund et al. 1998; Sohocki et al. 1998; Rivolta et al. 2001), 
NRL(Bessant et al. 1999), and Nr2e3 (Haider et al. 2006) have been associated with retinal diseases 
such as autosomal dominant Retinitis Pigmentosa, Leber’s congenital amaurosis, and enhanced S-cone 
syndrome. Thus, study of the rod photoreceptor cell has clinical importance. 
Taken together, the mammalian retina allows for the study of cis-regulation in a well-
characterized developmental environment where the tissue is highly accessible. In addition, the findings 
of this study and the development of future quantitative models of gene expression will have important 
implications for the treatment of human diseases.  
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Scope of Thesis Work 
The central goal of my thesis is to develop a high-throughput multiplexed reporter assay that can 
be used to understand the rules governing cis-regulation in the mammalian retina. To address reporter 
assay problems related to low throughput construction and serial analysis, I set out to develop a 
technique where I could clone and measure thousands of reporter genes in a single experiment. Given 
the increasing accessibility of next-generation sequencing, I chose to read out the expression of the 
reporter gene constructs with RNA sequencing. Because every construct contains identical reporter gene 
sequences, I cloned a short barcode sequence into the 3’UTR of the reporter gene so I could differentiate 
between reporter genes by sequencing the barcoded transcript. I cloned a unique CRE upstream of the 
barcoded reporter gene to generate a library of constructs, so that each CRE controls the level of a 
particular barcoded reporter gene. I developed this technique in collaboration with Dr. Joseph Corbo’s lab 
(Washington University in St. Louis School of Medicine) for use in explanted mammalian retinal cells, but 
this technique can be generalized to study the function of any regulatory elements in most cell types or 
tissues of interest. 
In Chapter 2, I describe CRE-seq, the method we have developed for multiplexed reporter 
analysis and I use the technique to understand how every nucleotide in central portion of the Rhodopsin 
promoter contributes to the control of gene expression. In total, we measured the impact of 156 single 
nucleotide substitutions and found that the majority of these substitutions (86%) had a significant effect on 
the control of gene expression. We observed that the largest changes in expression were caused by 
those mutations located in annotated TFBS. In addition, we were able to test a subset of double 
combinations of variants (819 of 11,934). Comparison of expression driven by CREs with one and two 
variants allowed us to conclude that most (82%) combinations of variants generate complex expression 
patterns that are non-additive. These data suggest that sequence variants alter expression through 
binding site creation and nucleotide changes have the most effect in TFBS, as a result of cooperative and 
competitive interactions between regulating TFs. Taken together, we find that most substitutions have a 
significant impact on the control of expression and combinations of substitutions often control expression 
that is not predicted from single substitution expression levels.  
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In Chapter 3, I discuss my ongoing work to understand how combinations of TFBS control gene 
expression. To answer this question we constructed synthetic CREs from combinations of CRX and NRL 
TFBS and measured expression controlled by 1300 of these synthetic elements. This set includes all 
CREs composed of one, two, or three TFBS and a subset of the possible CREs composed of four TFBS. 
We find that synthetic elements composed of binding sites for both TFs drive the highest expression 
levels in this library, suggesting that CRX and NRL TFs may interact cooperatively. Surprisingly, we find 
that combinations of CRX binding sites control low levels of expression and can even repress expression 
below the promoter alone. From expression measurements made in CRX null retinas, we conclude that 
this repression is caused by CRX itself, rather than another TF that can recognize the CRX binding site. 
We also find that repression by CRX is dependent on the absence of NRL binding sites. Taken together, 
we observe complex patterns of gene expression driven by simple synthetic CREs and we hypothesize 
that TF cooperativity and dual regulation underlie these patterns. 
In addition to the main focus of my thesis, Appendices 1 and 2 describe collaborative work to 
develop and apply this technique in new biological systems. In Appendix 1, I describe our work to develop 
CRE-seq in S. cerevisiae in order to interrogate the impact of TFBS affinity on transcriptional regulation. 
To accomplish this, we constructed synthetic promoters composed of TFBS with various affinities, used 
CRE-seq to measure the expression driven by these synthetic elements in the yeast genome, and 
modeled the resulting expression with a statistical thermodynamic model of gene expression. We found 
that a thermodynamic framework can accurately estimate the in vivo affinity of TFBS and that TFBS 
affinity can have unpredicted effects on control of gene expression due to altered affinity for cognate and 
non-cognate TF binding.  
In Appendix 2, I describe my work to use CRE-seq to test ENCODE Consortium enhancer 
predictions (Dunham et al. 2012; Hoffman et al. 2013). As part of the ENCODE project the human 
genome was annotated with functional classes, including Enhancer, Weak Enhancer and Repressed 
predicted activities. We chose a subset of these predictions and tested for the ability of these sequences 
to drive gene expression in the K562 cell line. We found that ENCODE Enhancer and Weak Enhancer 
predictions drive expression that is different from negative controls, whereas Repressed and H1-hESC 
Enhancer sequences controlled expression that was indistinguishable from controls. Based on linear 
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regression models we found that the presence of TFBS motifs, rather than levels of histone modifications, 
were most predictive of active sequences. We concluded that ENCODE enhancer predictions identify 
active enhancers, but the TF binding preferences are most predictive of cis-regulatory activity. 
This body of work makes several contributions to the field of transcriptional regulation. First, the 
development of CRE-seq allows for high throughput reporter gene analysis. This technique makes the 
study of cis-regulatory sequences considerably faster and easier than previous methods. Second, this 
study provides the first detailed examination of how sequence variants impact the activity of a mammalian 
promoter. In particular, the Rho promoter is relevant to human health and this study serves as a first step 
toward the interpretation of variation in this sequence.  Finally, this study adds to our knowledge of how 
TFBS regulate expression, particularly in the mammalian rod photoreceptor cell.  
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ABSTRACT 
Cis-regulatory elements (CREs) control gene expression by recruiting transcription factors and 
other DNA binding proteins. We aim to understand how individual nucleotides contribute to the function of 
CREs. Here we introduce CRE-seq, a high-throughput method for producing and testing large numbers of 
reporter genes in mammalian cells. We used CRE-seq to assay over 1000 single and double nucleotide 
mutations in a 52-bp CRE in the Rhodopsin promoter that drives strong and specific expression in 
mammalian photoreceptors. We find that this particular CRE is remarkably complex. The majority (86%) 
of single nucleotide substitutions in this sequence exert significant effects on regulatory activity. While 
changes in the affinity of known transcription factor binding sites (TFBS) explain some of these 
expression changes, we present evidence for complex phenomena including binding site turnover and TF 
competition. Analysis of double mutants revealed complex, nucleotide-specific interactions between 
residues in different TFBS. We conclude that some mammalian CREs are finely tuned by evolution, and 
function through complex, non-additive interactions between bound TFs. CRE-seq will be an important 
tool to uncover the rules that govern these interactions. 
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INTRODUCTION 
Mutations in cis-regulatory elements (CREs) often have unexpected effects on gene regulation. 
We lack models with the predictive power to accurately interpret the functional consequences of non-
coding polymorphisms. More generally, we do not understand the nucleotide-level architecture that 
distinguishes true CREs from non-functional groupings of transcription factor binding sites. While 
consortium-driven efforts continue to predict that large numbers of mammalian sequences are CREs 
(Birney et al. 2007; Bernstein et al. 2010), we lack a corresponding high-throughput method for 
functionally analyzing the consequences of variants in these elements. Addressing these problems 
requires fine structure mutational analysis of mammalian CREs on a large scale, experiments which are 
difficult to perform using traditional assays. To facilitate such experiments we developed CRE-seq (cis-
regulatory element analysis by sequencing) a high-throughput reporter gene assay for mammalian cells. 
CRE-seq leverages recent advances in oligonucleotide (oligo) synthesis (LeProust et al. 2010) 
and high-throughput sequencing (Mardis 2008). Using array based oligo synthesis we construct large 
numbers of reporter genes with unique sequence barcodes in their 3’ UTRs. These libraries of barcoded 
reporter genes are then transfected, en masse, into mammalian cells and quantified by performing RNA-
seq (Mortazavi et al. 2008) on the sequence barcodes. Here we present a study using CRE-seq to 
dissect a cis-regulatory element in mouse Rhodopsin (Rho), a gene that is expressed strongly and 
specifically in the mammalian retina. 
Tight control of Rho expression is critical for the function of mammalian retinas (Olsson et al. 
1992; Humphries et al. 1997). Rho expression is regulated in mice by multiple CREs located at varying 
distances from the transcription start site (Hsiau et al. 2007; Corbo et al. 2010). These elements are 
occupied in vivo by CRX, a retinal homeodomain TF (Corbo et al. 2010). One of these CREs, RhoCRE3, 
is located immediately upstream of the TSS and is sufficient to drive high levels of expression in rod 
photoreceptors (Lem et al. 1991; Zack et al. 1991). This element contains binding sites for CRX, and for 
NRL, a retina-specific basic-leucine-zipper protein (Chen and Zack 1996; Rehemtulla et al. 1996). How 
individual nucleotides within RhoCRE3 contribute to its function is not clear. To elucidate the functional 
architecture of RhoCRE3 we used CRE-seq to analyze the effects of more than 1000 variants of this 
element.   
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RESULTS 
We developed CRE-seq, a method that parallelizes the construction and measurement of 
mammalian reporter genes. Using high-throughput oligo synthesis (LeProust et al. 2010) we created 
1,040 variants of RhoCRE3, including all possible single nucleotide substitutions (156 mutations), and a 
large number of double substitutions (819 mutations). We also synthesized the wild type RhoCRE3 
sequence 65 times to include as controls. Each mutant RhoCRE3 was synthesized adjacent to a unique 9 
bp sequence barcode. To provide redundancy in the experiment, each single mutant was attached to ten 
different unique barcodes and each double mutant was attached to five unique barcodes. We then cloned 
the native Rho minimal promoter driving the fluorescent protein DsRed between the RhoCRE3 variants 
and their identifying barcodes. In the final plasmid library RhoCRE3 variants were located in a position 
immediately upstream of the TSS, surrounded by the same context sequence as in the endogenous Rho 
gene. The library contains 5,720 distinct reporter genes, each with a unique sequence barcode in the 3’ 
UTR of the DsRed gene (Fig. 2.1A). We electroporated this library into explanted newborn mouse retinas 
(Hsiau et al. 2007). Using DsRed to monitor the progression of the experiment we confirmed that library 
expression was specific to rod photoreceptors (Fig. 2.1B), the cell type in which Rho is expressed. 
We measured the expression of all library members using high throughput sequencing. After 
growing the electroporated retinal explants in culture we extracted both RNA and DNA, and sequenced 
the barcodes from both samples. The expression level of each barcoded reporter gene was calculated as 
the cDNA barcode sequence counts normalized to the DNA barcode counts (Table 2.S1). To test the 
reliability of CRE-seq, we compared the expression of twelve RhoCRE3 variants measured by both CRE-
seq and by a standard fluorescence reporter assay (Lee et al. 2010). We observed strong correlation 
between both measurements (R2=0.95, Fig. 2.1C), providing evidence that CRE-seq accurately quantifies 
gene expression in this system.  
In a previously reported in vitro multiplex reporter gene assay (Patwardhan et al. 2009), sequence 
barcodes were placed adjacent to the transcription start site and had large effects on reporter gene 
expression. To ameliorate this problem we placed our barcodes in the 3’ UTR of DsRed, far from the start 
site of transcription. To demonstrate that the barcodes do not interfere with our assay, we performed an 
experiment in which we fused more than 100,000 different barcodes to a single promoter, the wild-type 
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RhoCRE3, and measured the expression of this control library in electroporated retinas. If barcodes 
exerted a consistent effect on expression, we would expect to observe a correlation between replicates of 
this control library as barcodes with an activating effect would reproducibly increase expression while 
barcodes with a repressive effect would reproducibly decrease expression. No such correlation was found 
(R2=0.04, Fig. 2.S1A), which suggests that the variation between members of the control library resulted 
from experimental noise rather than the barcode sequences. In contrast, the correlation between 
replicates of our library of RhoCRE3 mutants was high (R2=0.95, Fig. 2.S1B, Table 2.S2). Taken together 
our results suggest that the 3’ UTR barcodes have little effect in our assay, and that there are strong and 
reproducible differences between RhoCRE3 variants in our library. 
 
Analysis of Single Mutants 
We first analyzed expression data from single nucleotide substitutions in RhoCRE3. We found 
that 86% of single nucleotide substitutions significantly alter expression (Welch’s t-test, p<0.05), with 
many substitutions causing large changes (>30-fold) in expression (Fig. 2.2A). For 98% (51/52) of the 
positions in RhoCRE3 at least one of the three possible substitutions had a significant effect on reporter 
gene expression. At 20% of positions different substitutions showed opposite effects on expression 
depending on the identity (A, G, C, or T) of the substituted base. Our results suggest that RhoCRE3 is an 
element whose function is finely tuned and that the majority of single nucleotide substitutions alter this 
function.  
This finding differs dramatically from those of Melnikov et al. (Melnikov et al. 2012) and 
Patwardhan et al. (Patwardhan et al. 2012), two recent studies which use methods similar to CRE-seq to 
analyze mammalian enhancers. In these studies very few single nucleotide substitutions resulted in 
significant changes in expression. All single nucleotide changes in Melnikov et al. and Patwardhan et al. 
showed changes less than 3.5-fold, with the vast majority of effects less than 1.5-fold. In contrast, 49% of 
the single nucleotide substitutions we measured had effects between 3.5-fold and 30-fold. This sharp 
difference in results may reflect functional differences between the CREs in each study, or may be due to 
differences in the technologies employed by the different groups.  
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Single mutants with significant effects delineate five distinct regions across RhoCRE3 (Fig. 2.2A). 
Regions A and E contain known CRX sites and region D contains a known NRL site (Chen and Zack 
1996; Rehemtulla et al. 1996). Regions B and C do not correspond to previously identified regulatory 
sequences in RhoCRE3. Regions of RhoCRE3 that show evolutionary conservation in mammalian 
lineages coincide with regions that have strong effects on expression (Fig. 2.2B). However, the modest 
correlation between effect size and conservation (R2=0.31) shows that the degree of conservation does 
not quantitatively predict the effect size of individual mutations, though it does delineate functional 
regions. 
 
Binding Site Mutations 
We examined the behavior of mutations in regions A and E, the known CRX binding sites, as well 
as region D, the region that contains the known NRL binding site. We generated activity logos (Shin et al. 
2000) for these regions using the single nucleotide substitution data (Figs. 2.S2A-C). Using the average 
log-likelihood ratio (ALLR) test (Wang and Stormo 2003) we found that the activity logos for regions A and 
D are similar (p<0.05) to Position Weight Matrices (PWMs) generated for these TFs in previous studies 
(Kataoka et al. 1994; Lee et al. 2010). Although there is a validated CRX site in region E, the activity logo 
made from region E does not show statistically significant similarity to the CRX PWM (p=0.22), but does 
show qualitative similarity. This finding suggests that the effect of mutations on expression do not depend 
solely on their effects on TF binding affinity, an issue we next addressed in more detail. 
 We examined the quantitative relationship between the predicted affinity of sequences for CRX 
or NRL and gene expression levels. Using a Position Weight Matrix (PWM) model of CRX specificity 
derived from quantitative in vitro gel shift assays (Lee et al. 2010) we computed the predicted change in 
affinity for each mutation in regions A and E for CRX. We then compared the predicted effect of each 
mutation on CRX affinity to its observed effect on expression (Fig. 2.2C). We performed a similar analysis 
for region D using a PWM that describes NRL binding specificity (Kataoka et al. 1994). For all three sites 
the wild-type sequence was predicted to have high relative affinity and drove high expression. However, 
while mutations that decrease predicted affinity tended to have lower expression, overall the correlation 
between predicted affinity and observed expression was modest (R2 = 0.22 CRX(1); R2 = 0.10 CRX(2); R2 
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= 0.41 NRL). In all three regions several mutations that create sequences with predicted affinity as high 
as the wild-type sequence exhibit markedly decreased expression. Our data suggest that variables 
besides the affinities of CRX and NRL also help determine the in vivo activity of RhoCRE3 variants. 
Mutations in the binding sites for CRX and NRL may have effects on the binding of other TFs. 
Regions A, D and E of RhoCRE3 contain binding sites for known transcriptional activators (CRX, 
NRL), and accordingly these regions contain dense clusters of single nucleotide substitutions that 
decrease expression (Fig. 2.2A). Because region C shows a similar pattern of variants with decreased 
expression, we hypothesize that it also represents a TFBS. Using the single mutant expression data we 
created an activity logo of this sequence (Fig. 2.S2D). The activity logo generated for region C does not 
match any of the sequence logos in the Transfac database (Wingender et al. 1996), which suggests that 
if these mutants effect the binding of a TF, it is a TF whose binding specificity has yet to be determined. 
However, the activity logo for the region overlapping with region B does show similarity to the CRX PWM 
(p<0.05, ALLR test), which suggests that many mutations in region B exert their effects by creating a CRX 
site (Fig. 2.S2E).  
Region B is qualitatively different from the other regions of RhoCRE3 in that substitutions in 
region B often increase, rather than decrease expression. This finding suggests that mutations in region B 
either disrupt a binding site for a repressor or create new binding sites for activators. Because the density 
of mutations with large effects in this region is less than the density in regions with known TFBS, we favor 
the hypothesis that these mutations create binding sites for an activator. An obvious candidate for this 
activator is CRX. 
To identify mutations that create CRX binding sites, we searched the entire library of single 
nucleotide mutants for matches to the CRX PWM. Mutations that create sequences with low predicted 
affinity to CRX are marked with an asterisk in Figure 2.2A. Surprisingly, mutations that create putative 
CRX sites, as defined by a PWM score threshold, are not distributed randomly throughout RhoCRE3; 
rather, these mutations cluster in regions B and D. This finding suggests that both regions B and D 
contain sequences that are very close to CRX binding sites. We analyzed these sequences in more 
detail. 
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Region B corresponds to a region of high evolutionary conservation in vertebrates. We scanned 
the orthologous regions from multiple vertebrate species with our CRX PWM and found that in most other 
mammals region B contains a sequence with a low affinity match to CRX PWM (Fig. 2.S3). The presence 
of this putative low affinity CRX site in most mammals accounts for the strong evolutionary conservation 
of region B. However, neither the rat nor the mouse genome has a potential CRX site in region B as 
defined by the same PWM score threshold. Using a neutral rate of 0.233 substitutions/site (Chun and Fay 
2009) the three observed differences between mouse and rat in region B are not significantly different 
from the 2.33 that are expected under neutrality. This finding suggests that these two species are 
accumulating substitutions in region B at a rate consistent with neutral evolution, and that there has been 
recent turnover of CRX sites in region B in the rodent lineage. Taken together these results suggest that 
mutations in region B that create CRX sites increase expression by re-creating sequences that resemble 
the ancestral form of RhoCRE3. 
In contrast to region B, all mutations that create sequences matching CRX sites in region D 
decrease expression. In region D these new hypothetical CRX sites disrupt the known NRL site. These 
overlapping CRX and NRL binding sites create complex expression patterns that suggest competition 
between the two factors. For example, mutations at position 36 suggest competition between NRL and 
CRX binding. All three substitutions at position 36 increase the predicted affinity of NRL, but only the two 
substitutions that also decrease the predicted affinity of CRX increase expression (Fig. 2.3). Only some 
mutations in region D support the competition model suggesting that other factors play a role in regulation 
of region D (Fig. 2.S4). Further experiments are needed to determine whether CRX and NRL actually 
compete for binding to the sequence in region D.  
 Other position specific effects on expression cannot be explained by CRX and NRL site affinity. 
For example, mutations at position 42 have a dramatic effect on expression but a relatively minor effect 
on predicted NRL or CRX affinity. Mutations at position 42 may create a new TFBS (Fig. 2.S2F) or alter 
the DNA helix structure (Fig. 2.S5) (Parker et al. 2009; Bishop et al.).  
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Analysis of Double Mutant CRE Variants 
Our library also contained all possible double mutations between the NRL site in region D and the 
CRX site in region E. On average, the double mutant RhoCRE3 variants have lower expression than the 
single mutants (p<0.05, Wilcoxon). In addition, many (58%) double mutants have effect sizes that are 
larger than either of their component single mutations. We used linear modeling (Methods) to identify 
significant non-additive interactions between mutations, and if present, to determine the strength and 
direction of such interactions. Using ANOVA we found that 82% of double mutants have a significant 
interaction between positions that cannot be explained by an additive model of single mutant expression 
values (p<0.01, F-test). Our results contrast with those of Melnikov et al. (18) and Patwardhan et al. (19), 
who found very few interactions between mutations in enhancers. Our data show that some positions 
have interactions with many other positions, while other positions do not participate in any interactions 
(Fig. 2.4A). For some positions a particular substitution can have an interaction that is either more or less 
than additive, depending on the position of the second mutation (Fig. 2.4B).  
In addition we observed that interactions between pairs of mutations are usually nucleotide-
specific, rather than position specific. Most models are improved with the addition of some, but not all of 
the nine possible interaction terms (p<0.01, F-test). Mutations at two particular residues can combine to 
be either more or less than additive, depending on the specific identities of the substituted nucleotides 
(Fig. 2.4C). Combinations of mutations give rise to expression levels that cannot easily be predicted given 
the expression levels of single mutants. Physical interactions between NRL and CRX (Mitton et al. 2000) 
likely underlie some of the complexity we observe, but more detailed physical models will be required to 
unravel the molecular basis of these non-linear genetic interactions. 
 
DISCUSSION 
Using CRE-seq we found that single nucleotide substitutions in RhoCRE3 often result in large 
increases or decreases in expression, suggesting that this element may be highly constrained as to which 
mutations it tolerates through evolution, a hypothesis supported by the strong evolutionary conservation 
of this region. Changes in the predicted affinity of TFBS to known TFs partially explain the effects of these 
mutations, but cannot explain the full in vivo activity of substitutions. More complex phenomena such as 
20 
recent binding site turnover as well as competition between CRX and NRL may help explain the effects of 
some substitutions. The fact that the majority of double mutants have expression levels consistent with a 
non-additive model between positions suggests that interactions between CRX and NRL underlie some of 
the complex behaviors of RhoCRE3 mutants. Consistent with the many other studies, our results suggest 
that the interpretation of non-coding polymorphisms will require consideration of both low affinity sites and 
the creation of novel sites. Overall our results paint a picture of CREs as complex regulatory elements 
whose function can easily be altered by subtle changes to their nucleotide sequences.  
In contrast, Melnikov et al. (18) and Patwardhan et al. (19) conclude that cis-regulatory elements 
are largely redundant at the nucleotide level, such that few mutations create large changes in expression. 
Our results showing large effects of single nucleotide substitutions agree with many detailed studies of 
single reporter genes, for example (Weiher et al. 1983; Myers et al. 1986; Goodbourn and Maniatis 1988; 
Singh et al. 1989; Smith et al. 1990; Shimell et al. 1994; Gurnett et al. 2007; Lettice et al. 2012; Yun et al. 
2012). We also show evidence for extensive non-linear interactions between CRE mutations, while both 
Melnikov et al. (18) and Patwardhan et al. (19) conclude that mutations in enhancers act independently of 
each other. What might account for these dramatic differences in conclusions? 
Some differences between these studies and our study are likely due to the CREs each group 
chose to examine. We chose to study an extensively validated CRE (Hsiau et al. 2007; Corbo et al. 2010) 
that drives the expression of Rhodopsin, the most highly expressed gene in the mammalian retina. This 
element shows strong evolutionary conservation throughout the vertebrate lineage and lies proximal to 
the start site of transcription. These features may make RhoCRE3 activity in CRE-seq susceptible to 
substitutions in ways that other cis-regulatory elements are not.  
Technical differences between protocols probably contribute to some of the differences between 
these studies. Template switching during the PCR cycles used for library preparation can result in high 
rates of chimerism (Stemmer 1994), which can disrupt the unique correspondence between CRE variants 
and barcodes. Chimerism decreases both the accuracy and the dynamic range of the assay. In Melnikov 
et al. (18) and Patwardhan et al. (19) limited dynamic range due to the extensive use of PCR may have 
made it appear that enhancers are robust to mutation. In contrast, our method makes limited use of PCR 
amplification (Methods) to avoid the creation of chimeras. Finally, we chose to focus on only 1,040 
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mutations in a single experiment, which allowed us to obtain very high sequence coverage of our library. 
Both Melnikov et al. (18) and Patwardhan et al. (19) assayed much larger numbers of mutant promoters, 
making low sequence coverage and the resulting loss of statistical power a significant issue in these 
studies. In Patwardhan et al. (19) low sequence coverage of their library necessitated the use of an 
indirect measure of barcode counts as the metric of expression. 
 We have demonstrated that CRE-seq is a robust technology for assaying large numbers of CRE 
mutations. CRE-seq has a large dynamic range, nucleotide level resolution, and excellent reproducibility. 
Our analyses revealed a surprising amount of previously unknown complexity in RhoCRE3, an element 
that has been extensively studied. Our results demonstrate that nucleotides within CREs interact in 
complex, and often non-intuitive ways to produce regulated patterns of gene expression. We anticipate 
that CRE-seq will be an important tool for unraveling the rules that govern the function of CREs.  
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MATERIALS AND METHODS 
 
CRE-seq Library Construction 
To create the CRE-seq library plasmid backbone, we replaced the NotI site in plasmid 
Rho_minprox-DsRed (Hsiau et al. 2007; Corbo et al. 2010) with an EagI-XhoI-ClaI polylinker, creating 
plasmid pJK01. We then engineered sites for MfeI at position 25 and KasI at position 102 (following the 
numbering in (Hsiau et al. 2007; Corbo et al. 2010)), creating pJK02.  
The wild type RhoCRE3 sequence spans positions 115,881,830-115,881,881 on mouse 
chromosome 6 (NCBI37/mm9). This region corresponds to the sequence between positions 68 and 120. 
A pool of 5720 unique 150-mer oligonucleotides (oligos) was ordered through a limited licensing 
agreement with Agilent Technologies. Oligos were designed with the following structure: JKP1F, MfeI 
site, RhoCRE3 variant, KasI site, EcoRI site, EagI site, 9 bp barcode, ClaI site, and JKP1R (Table 2.S1). 
RhoCRE3 variants were designed between positions 68 and 120.  
We amplified the oligo pool using 4 cycles of PCR with Phusion High-Fidelity polymerase (New 
England Biolabs, Beverley, MA) and primers JKP1F and JKP1R(Table 2.S1). We cloned the amplicon 
into pJK02 using MfeI and ClaI. We prepared DNA from 48,000 colonies to generate library PL5_1. We 
then cloned the minimal Rho promoter driving DsRed into PL5_1. A cassette containing the Rho minimal 
promoter fused to DsRed was amplified from pJK02 with primers JKP2F and JKP2R (Table 2.S1). The 
PCR amplicon was cloned into library PL5_1 using KasI and EagI, creating library PL5_2. To select for 
library members with full-length RhoCRE3 variants, we linearized PL5_2 with HindIII, gel purified the 
library, and re-circularized to create library PL5_3. 
We created library (BL_1) to determine the effect of barcode sequences on reporter gene 
expression. Barcode sequence inserts, JKP5F and JKP5R (Table 2.S1), were annealed and cloned into 
pJK01 using EagI and ClaI. We prepared library DNA from 100,000 colonies. 
 
Retinal Electroporation 
Electroporations and explant cultures were performed as previously described (Hsiau et al. 2007) 
using 0.5 µg/ml of library PL5_3 as well as 0.5 µg/ml Rho minimal promoter driving GFP for visualization 
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of electroporation efficiency (Lee et al. 2010) . After 8 days in culture retinas were washed twice in sterile 
HBSS (Gibco, Life Technologies, Grand Island, NY), and total RNA and DNA were extracted using Trizol 
according to manufacturer's instructions (Ambion, Life Technologies, Grand Island, NY).  
 
Comparison Between a Fluorescence Assay and CRE-seq 
Twelve previously characterized RhoCRE3 variants (Lee et al. 2010; Montana et al. 2011b) were 
excised from their respective vectors with XbaI and KpnI and cloned into the barcode library BL_1. For 
each variant we isolated ten uniquely barcoded constructs. We mixed all 120 constructs together for 
CRE-seq analysis. 
 
Preparing Samples for RNA-Seq 
Isolated RNA was treated with DNAseI (Ambion) to eliminate potential genomic DNA 
contamination. The first strand of cDNA was synthesized with Invitrogen Superscript II reverse 
transcriptase using oligo-dT primers. After first strand synthesis, the reaction was treated with RNAse H 
(NEB) to remove RNA. The 3’ UTR of the DsRed gene including the barcode sequence, was amplified 
from both cDNA and isolated plasmid DNA samples. Amplification (98°C for 1min, 21 cycles: 98°C for 
10s, 58°C for 30s, 72°C for 30s, and 72°C for 5 min, NEB HF Phusion MM) of the cDNA and plasmid 
DNA samples isolated by PCR using primers JKP3F and JKP3R (Table 2.S1) yielded barcode sequences 
that are flanked with EagI and EcoRI restriction enzyme sites. The products were purified with Qiagen 
QIAquick PCR Purification kit and digested with EagI and EcoRI. Illumina adapter sequences were ligated 
onto these overhangs. This product was amplified (98°C for 1 min, 21 cycles: 98°C for 30s, 65°C for 30s, 
72°C for 30s, and 72°C for 5 min) with HF Phusion MM using primers JKP4F and JKP4R (Table 2.S1) to 
enrich for molecules that contain both adapter sequences. 
To measure expression of the barcoded library, electroporation replicates were multiplexed and 
run on two lanes of an Illumina HiSeq machine which generated 48.2 million sequence reads 
corresponding to cDNA and 48.8 million reads corresponding to DNA. Sequencing reads that matched 
the first 20 nucleotides of designed sequence were counted, regardless of quality score. Only barcodes 
with more than 10 reads in either cDNA or DNA pools were used for analysis.  
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Determination of Expression Levels of Rho Variants 
We determined the expression levels of each RhoCRE3 variant by computing the average 
cDNA/DNA ratio for all barcodes that marked the same RhoCRE3 variant (Table 
 2.S2). We also computed the standard error of the mean (SEM) for each average in each 
replicate. We then averaged the averages from the three replicates and propagated the standard error 
using the formula:  
!" !!! =    !" !!! ! 
The propagation of standard error when computing the ratio of mutant to wild-type expression levels was 
calculated as: 
!" !!"#!!" =    !!"#!!!"! !" !!"# !!!"#! +    !" !!" !!!"!  
 
Analysis of Binding Site Mutations 
The CRX position weight matrix was derived from quantitative binding affinity data (Lee et al. 
2010) according to (Stormo and Fields 1998). Similarly, a NRL position weight matrix was derived from 
sequence data from (Kataoka et al. 1994). The two TF matrices were scored against every position of 
each CRE variant using patser (Stormo et al. 1982). 
 
Non-additive Model for Variants with Two Substitutions 
Linear regression was used to determine the extent of non-additive expression in the variants 
with two substitutions. First, the following two models were generated for each combination of positions 
and compared using an ANOVA (p<0.01).  !!,! = !" +   !!!"!! + !!!"#! !!,! = !" +   !!!"#! + !!!"#! +   !!!"#!,!   
Models that were significantly improved (82%, 75/91) by the addition of the interaction term were 
further analyzed for base-specific interactions. After selecting positions with significant non-additive 
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expression, we used ANOVA (p<0.01) to test each of the nine possible base-specific interactions 
between positions.  
All experiments were conducted in accordance with the Guide for the Care and Use of Laboratory 
Animals and the Animal Welfare Act and were approved by the Washington University in St. Louis 
Institutional Care and Use Committee. 
  
26 
FIGURE 2.1 
 
Figure 2.1 (A) Schematic of the CRE-seq method. Each CRE variant in the library is fused to a reporter 
gene marked by a unique DNA barcode in the 3’ UTR of DsRed. The library is electroporated into 
newborn mouse retinas, which are cultured as explants for eight days. Barcodes are then sequenced 
from harvested mRNA and DNA. The cDNA/DNA ratio of each barcode is a quantitative measure of the 
expression levels driven by each CRE variant in the library. (B) Cell type specificity of the CRE-seq 
library. A cross section of an electroporated retina shows DsRed expression in rod photoreceptors 
residing in the outer nuclear layer (ONL). Green fluorescence driven by a ubiquitously expressing CAG-
GFP construct is observed in all layers including the inner nuclear layer (INL) and the granular cell layer 
(GCL). (C) Correlation between CRE-seq and fluorescent reporter genes. Twelve RhoCRE3 variants 
were quantified using a standard dual color fluorescent reporter gene assay (Lee et al. 2010; Montana et 
al. 2011b) and also using CRE-seq. X-axis, CRE-seq expression, log2(variant RhoCRE3/wild-type 
RhoCRE3); Y-axis, fluorescent reporter gene expression, log2(fluorescence of variant 
RhoCRE3/fluorescence of wild-type RhoCRE3). 
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FIGURE 2.2
 
Figure 2.2 (A) Effects of single nucleotide mutations on reporter expression. X-axis, nucleotide position in 
RhoCRE3; Y-axis, relative expression by CRE-seq quantified as the log2(variant RhoCRE3/wild-type 
RhoCRE3). Colored bars represent substitutions whose expression was significantly different from wild-
type (Welch’s t-test, p<0.05). Gray bars represent substitutions that are not significantly different from 
wild-type. Each position has three bars representing the three possible substitutions at that position. For 
analysis we divided RhoCRE3 into five regions (A-E). Experimentally validated binding sites for CRX and 
NRL are shaded in gray. Asterisks mark the locations of substitutions that create new CRX binding sites 
(≥2% predicted affinity relative to consensus). (B) Phylogenetic conservation of nucleotides in RhoCRE3. 
X-axis, position in RhoCRE3; Y-axis PhastCons score derived from a multiple alignment of twenty-eight 
mammalian sequences (Miller et al. 2007). (C) Relationship between the effects of mutations on the 
predicted binding affinity of TFs versus the mutations’ effects on gene expression. X-axis, predicted 
affinity of RhoCRE3 mutations for CRX or NRL; Y-axis, observed effects of mutations on gene 
expression. In each graph the red dot represents the wild type sequence of RhoCRE3 and the blue line 
represents the linear regression model.  
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FIGURE 2.3 
 
 
Figure 2.3 Complex interactions between CRX and NRL in region D. The effects of mutations at 
position 36 support a model of competition between NRL and CRX. The X-axis shows the identity of the 
base at position 36. Red bars, relative affinity of CRX normalized to the wild type sequence. Blue bars, 
relative affinity of NRL normalized to the wild type sequence. Green bars, expression normalized to the 
wild type sequence. Errors bars represent the standard error of the mean.  
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FIGURE 2.4 
 
 
Figure 2.4 Interactions between mutations in TFBS within regions D and E. (A) Pattern of 
interactions. Each arc connects two nucleotides that have a significant interaction term by ANOVA 
(Methods). The height of the arc represents the magnitude of the interaction term. Only interactions 
greater than 3 or less than -3 are shown. (B) The magnitude and direction of interactions are position 
specific. The interaction between mutations 40A (CRX) and 49A (NRL) is significantly more than additive 
and greater than the effect of either single mutant, while the interaction between mutations 40A and 47C 
(NRL) is less than additive and greater than the effect of either single mutant. (C) Interactions between 
the same positions are base specific. The interaction between 41A (CRX) and 46A (NRL) is significantly 
more than additive, while the interaction between 41T and 46A is less than additive.   
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SUPPLEMENTARY FIGURES AND TABLES 
TABLE 2.S1 
 
 
Table 2.S1 Primer sequences used in this study. 
 
 
 
Name Primer sequence 
JKP1F TGCAAGCCAATTGGGCCCCGGT 
JKP1R GGAGTGCGGCCATCGATGCG 
JKP2F ATATCTCGCGGATGCTGAAT 
JKP2R TATTTGTGAGCCAGGGCATT 
JKP3F TGTTCCTGTAGCGGCCGACG 
JKP3R GAATTCTAGCCAGAAGTCAGATGCTCAAG 
JKP4F AATGATACGGCGACCACCGAG 
JKP4R CAAGCAGAAGACGGCATACGA 
JKP5F GGCCGACGNNNNNNNNNNCGCAT 
JKP5R CGATGCGNNNNNNNNNNCGTC 
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FIGURE 2.S1
 
 
Figure 2.S1 Correlation between replicate experiments. (A) Barcodes do not impact expression. More 
than 100,000 distinct barcodes were fused to the wild-type RhoCRE3 sequence. Measurements in 
replicate experiments showed no correlation (R2=0.04) indicating that different barcodes do not have 
significant effects on reporter gene expression. (B) Mutant RhoCRE3 variants have strong effects on 
expression. The correlation between replicate experiments measuring the 1,040 RhoCRE3 variants is 
high (R2=0.95) indicating that the mutations have strong and reproducible effects on expression. 
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FIGURE 2.S2 
 
Figure 2.S2 Activity logos of known and hypothesized transcription factor binding sites. The 
activity logos of (A) region A and (B) region E correspond to the known sequence logo for CRX (depicted 
here in 'reverse' orientation). (C) The activity logo of region D corresponds to the known sequence logo 
for NRL (Kataoka et al. 1994). (D) Activity logo of region C. (E) Activity logo of the sequence joining 
regions D and E.  
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FIGURE 2.S3 
 
Figure 2.S3 RhoCRE3 sequence in mammals. The sequence of the RhoCRE3 element in 21 mammals 
and the platypus is shown. Red, sequences that match the CRX position weight matrix model. Blue, 
sequences that match the NRL position weight matrix model. Many of the species have a low affinity CRX 
site directly adjacent to the first known CRX site.  
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FIGURE 2.S4 
 
 
Figure 2.S4 The effects of mutations in region D. For each mutation in region D we plotted its effect on 
the predicted affinity of the NRL site (X-axis) and the CRX site (Y-axis). Each circle represents a single 
mutation in region D. The size and color of the circles show the effect on reporter gene expression. The 
square represents the wild-type sequence. 
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FIGURE 2.S5 
 
Figure 2.S5 Structural analysis of mutations at position 42. We used the program ORChID2 (Bishop 
et al.) to generate structural plots of the RhoCRE3 sequence between positions 30 and 52. We generated 
these plots for the wild-type sequence as well as the sequence containing the three possible substitutions 
at position 42. We computed the Euclidean distance between each sequence and the wild-type (x-axis) 
and compared these distances to the expression level driven by each variant (y-axis). Mutant 42G, which 
has the largest effect on expression, also has the largest predicted effect on DNA structure.  
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ABSTRACT 
The ability to predict gene expression from sequence is an unsolved problem in the field of the 
genetics. Successful prediction of gene expression levels will aid in the interpretation of human non-
coding sequence variation and allow us to engineer novel regulatory elements with desired expression 
patterns. There are a variety of methods to identify functional transcription factor binding sites (TFBS), but 
little understanding of how these binding sites combine to control gene expression. In the developing 
mammalian retina, transcriptional activators CRX and NRL regulate rod photoreceptor cell differentiation 
and homeostasis. In order to determine the rules that govern combinatorial regulation by CRX and NRL, 
we have examined the expression controlled by synthetic promoters composed of NRL and CRX TFBSs. 
We have used cis-regulatory element sequencing (CRE-seq), a high throughput reporter assay, to 
measure the expression controlled by these synthetic cis-regulatory elements (CREs) in explanted retinal 
cells.  We find there is a strong synergistic interaction between NRL and CRX binding sites and that CRX 
binding sites can switch from activating to repressing in different contexts. These results have major 
implications for our ability to interpret cis-regulatory sequence and will improve our ability to predict 
expression from genomic sequence. 
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INTRODUCTION 
cis-regulatory elements (CREs) are DNA sequences that regulate the expression of a nearby 
gene. CREs are composed of combinations of short transcription factor binding sites (TFBS), which are 
recognized by regulating transcription factors (TFs). TFs bind these sites and recruit RNA Polymerase II 
(RNA Pol II) machinery to initiate transcription. Transcriptional activators promote the recruitment of the 
polymerase machinery, whereas transcriptional repressors inhibit this recruitment. A major goal in the 
field of transcriptional regulation is to develop a quantitative understanding of how functional 
combinations of binding sites drive gene expression. 
There are a variety of methods to identify functional TFBS in a genome: directly measuring TF 
binding with chromatin immunoprecipitation (ChIP) (Harbison et al. 2004; Johnson et al. 2007; Visel et al. 
2009); identifying clusters of TFBS in co-expressed sequences (Beer and Tavazoie 2004; Elemento et al. 
2007); and transcriptional profiling of cells mutant for the TF of interest (Hu et al. 2007). These techniques 
provide insight into the genomic locations of functional TFBSs and are a first step in classifying 
combinations of binding sites that regulate a specific gene. The identification of binding sites alone does 
not provide information about how sequences control the level of gene expression, or how this expression 
might change as a result of removing, adding, or rearranging these binding sites.  In order to understand 
how these variables impact the control of expression, one needs to examine how systematic 
combinations of TFBS regulate gene expression levels. 
Generally speaking, scientists understand how combinations of binding sites control gene 
expression, but the field lacks a quantitative model to predict how much expression is produced by a 
sequence. In fact, we have little ability to predict the level of expression that is controlled by even a single 
DNA sequence. It would be useful to develop a quantitative model to predict expression for two reasons. 
First, the model would predict how gene expression level is modulated as a result of sequence 
perturbation. This would be useful in the interpretation of human non-coding variation, which can change 
affinity or number of regulating binding sites. Second, this model would predict the level of gene 
expression controlled by a synthetic DNA sequence. This would be useful when engineering a regulatory 
sequence to express at a desired level.  In order to develop quantitative models, we first need to deepen 
our understanding of how DNA sequence properties impact expression regulation. 
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Our approach is to gain an understanding of how simple CRE sequences control gene 
expression. In this study we examine gene expression controlled by CREs composed of only four 
different TFBS. This design allows us to characterize the relationship between expression controlled by a 
CRE and the properties of the TFBS in that CRE sequence. We vary TFBS identity, number, affinity, 
order and orientation but keep other variables constant, such as TFBS spacing and surrounding 
sequence. We anticipate that patterns found in the study of regulation by simple CREs will be relevant 
when predicting expression driven by complex regulatory elements that are composed of the same TFBS 
(Gotea et al. 2010).  
The mammalian retina is an ideal system for cis-regulatory analysis because it is an accessible 
tissue with well-characterized transcriptional regulators. The majority of cells in the mammalian retina are 
photoreceptors that express cascades of TFs to define cell identity during differentiation. Cone/Rod 
homeobox transcriptional activator CRX is expressed in the early stages of photoreceptor differentiation 
(Furukawa et al. 1999). In rod photoreceptor cells CRX activates expression of neural retina leucine 
zipper transcriptional activator NRL (Kautzmann et al. 2011; Montana et al. 2011a). CRX and NRL 
combine to transcriptionally regulate the level of photoreceptor genes that are critical for rod 
photoreceptor cell differentiation and homeostasis (Furukawa et al. 1999; Mears et al. 2001; Hsiau et al. 
2007). CRX and NRL have been shown to directly interact and regulate synergistically (Chen et al. 1997; 
Mitton et al. 2000), suggesting that the two TFs may cooperatively regulate expression. We anticipate that 
this study will not only inform our understanding of rod cell-specific gene regulation, but will also provide 
use as a general model of mammalian gene regulation.  
 
RESULTS 
 
CRE-seq Library and Measurements 
In order to understand how combinations of CRX and NRL transcription factor binding sites 
combine to regulate gene expression, we created a library of synthetic CREs (Ligr et al. 2006; Gertz and 
Cohen 2009; Gertz et al. 2009; Mogno et al. 2010; Sharon et al. 2012; Smith et al. 2013). These synthetic 
CREs are composed of: a high affinity CRX1 site, a low affinity CRX2 site, a predicted lower affinity CRX3 
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site (Lee et al. 2010), and a high affinity NRL site (Kataoka et al. 1994). Previous studies have shown that 
CRX binds the CRX1 and CRX2 binding sites in vitro (Lee et al. 2010) and that regulation of these binding 
sites in the Rhodopsin (Rho) promoter is critical for appropriate expression (Kwasnieski et al. 2012). In 
addition, we hypothesize that CRX can bind the CRX3 site based on evidence of TF competition 
(Kwasnieski et al. 2012) even though CRX3 has very low predicted affinity. Short constant buffer 
sequences were added to each binding site to maintain the helical spacing when binding sites were 
combined. Using these 4 TFBS, we generated all possible synthetic CREs that contain one, two, or three 
binding sites in both orientations. In addition, we generated 715 of the possible 4096 synthetic elements 
that are composed of four binding sites.  
We used CRE-seq, a high-throughput multiplexed reporter assay, to measure the expression 
controlled by these synthetic CREs (Kwasnieski et al. 2012). The library of CREs were cloned upstream 
of the rod cell-specific Rho proximal promoter driving the DsRed reporter gene. The expression of each 
synthetic CRE was measured by five unique barcodes to average any barcode-specific effects on 
expression. The library was electroporated into retinal explants and RNA was harvested after 8 days in 
culture. Expression was calculated as the number of times each barcode was sequenced from the RNA 
pool normalized to the number of times each barcode was sequenced from the original plasmid pool. We 
conducted four biological replicates of library expression (Figure 3.1A, R2 range=0.97 – 0.99). 
 
Synthetic CREs Control Diverse Expression Levels 
The library of synthetic CREs was composed of TFBS for transcriptional activators. We 
anticipated that expression controlled by long CREs would be higher than expression controlled by short 
CREs because we thought more activator binding sites would result in higher expression. Surprisingly, we 
observe that for every length CRE, some synthetic elements drive expression that is activated above the 
Rho proximal promoter, while other synthetic elements drive expression that is repressed below the Rho 
proximal promoter (Figure 3.1B). The range in expression levels is surprising given that the library was 
constructed with binding sites for transcriptional activators that are not predicted to repress gene activity. 
These data show that even simple combinations of TFBS can generate complex gene expression 
patterns that are not the additive expression of component parts.  
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Patterns in Regulation by CRX and NRL 
In order to understand how these TFBS could generate such a large range in expression values, 
we sought to identify the combinations of motifs that controlled high expression. Upon examination of 
synthetic CREs that are two TFBS in length, we find that CREs composed of CRX1 and NRL binding sites 
have significantly higher expression than CREs composed of only CRX1 or only NRL TFBS (Welch’s t 
test, P<0.01, Figure 3.2A). We observe the same relationship when we examine synthetic CREs 
composed of three TFBSs (Welch’s t test, P<0.01, Figure 3.2B). These data suggest that CRX and NRL 
synergistically regulate expression because combinations of CRX1 and NRL binding sites drive 
significantly higher expression than CRX1 or NRL binding sites alone. This result is supported by previous 
studies demonstrating that CRX and NRL synergistically regulate (Chen et al. 1997) and directly interact 
(Mitton et al. 2000). 
We sought to identify combinations of TFBS that control expression levels lower than the 
expression of the proximal promoter alone. By examining the lowest expressing CREs, we found that 
synthetic CREs composed of multiple CRX binding sites and few NRL binding sites drive expression that 
is repressed below the basal promoter alone (Figure 3.3A). This observation is not simply the absence of 
the CRX and NRL synergism because the addition of NRL binding sites increases expression level but 
does not relieve the trend that adding more CRX1 sites lowers expression (Figure 3.3B). Interestingly, we 
observe similar behavior for NRL binding sites where many NRL TFBS drive low expression (Figure 
3.S1), but these synthetic CREs are unable to repress the proximal promoter. There is little evidence to 
support CRX regulating as both an activator and a repressor (White et al. 2013). Previous studies (Smith 
et al. 2013) have observed low expression driven by homopolymers of binding sites and that 
homopolymers are capable of initiating heterochromatin formation (Bulut-Karslioglu et al. 2012).  
 
Repression is Dependent on CRX 
To determine whether CRX itself was regulating at the CRX binding site, or if another TF with 
similar specificity was responsible for this repression, we measured expression of the library in CRX-null 
retinas. We previously used CD wild-type mice for our experiments but the CRX null mouse was created 
42 
in a B6 background, so we measured expression of the library in the B6 wild-type mouse to retina ensure 
a proper wild-type control for the CRX null mouse (Figure 3.S2). High correlation (R2=0.96) between the 
wild-type expression measurements suggests that the genetic variation between the two mouse strain 
backgrounds does not impact library expression. 
Expression measurements from CRX null retinas have two striking patterns when compared to 
wild-type expression. First, we observe a population of synthetic elements that has relatively consistent 
expression between the wild-type and null mice and thus lies near the diagonal when wild-type and null 
expression measurements are compared (Figure 3.4). It has been suggested that the CRX null mouse 
has a milder phenotype than expected in part because Otx2, or another homeodomain transcription 
factor, is capable of compensating for CRX in the CRX null retina (Bovolenta et al. 1997; Furukawa et al. 
1999; Hennig et al. 2008). This regulatory compensation would explain why many synthetic CREs are still 
expressed in the null retina. Second, we observe a population of synthetic elements that drive low 
expression in the wild-type retina but increased expression in the CRX null retina. This population is 
largely composed of synthetic CREs that contain three or four CRX binding sites (Figure 3.4). These data 
suggest that the repression we observe in the wild-type mouse is driven by CRX, rather than another 
homeodomain TF, because we see expression increases when CRX is not present. These data also 
suggest that CRX repression is dependent on the absence of NRL TFBS because we see that synthetic 
CREs composed of NRL TFBS are consistently expressed between the wild-type and null conditions. 
 
DISCUSSION 
In this study we found that combinations of transcriptional activator binding sites generate diverse 
expression levels, where synergism between CRX and NRL binding sites drives high expression and 
CRX-dependent repression drives low expression. We were surprised to see that combinations of CRX 
binding sites not only drive low expression, but can also repress the Rho proximal promoter itself.  
We have developed two working models that might explain this observation.  
In our first model, we hypothesize that the proximal promoter needs to be occupied by NRL in 
order to activate transcription. In this model, interactions between CRX bound in the CRE and NRL bound 
in the proximal promoter would lower the NRL promoter occupancy and decrease the promoter’s ability to 
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recruit polymerase. This model predicts that if only NRL is required at the proximal promoter, rather than 
both CRX and NRL, CRX binding sites will not be able to repress the Rho proximal promoter with a 
mutant NRL binding site. This model also predicts that CRX binding sites will not repress a promoter that 
is not regulated by NRL. Previous studies have found that CRX has very little trans-activation potency but 
NRL can interact with TATA-binding protein (Chen et al. 1997; Friedman et al. 2004), which adds 
molecular support to this model.  
 In our second model, we hypothesize that there is some appropriate ratio of bound CRX to bound 
NRL that is necessary for expression activation. In this model, the presence of many CRX TFBS 
increases the occupancy of CRX, disrupting this stoichiometric relationship, and gene activity is 
repressed. This model predicts that synthetic CREs composed of many CRX TFBS would not repress if 
the appropriate number of NRL TFBS were included. These two models represent our ideas for how CRX 
TFBS would be able to repress the proximal promoter activity; we are conducting experiments and 
developing computational models to distinguish between these two scenarios.  
Previously, we have used a statistical thermodynamic framework to develop quantitative models 
of gene expression (Shea and Ackers 1985; Buchler et al. 2003; Gertz et al. 2009). This framework is 
powerful because it predicts expression with parameters that represent biophysical interactions, allowing 
us to gauge whether our understanding of the system is able to mathematically predict the behavior. In 
this study, we attempted to apply the thermodynamic framework in order to distinguish between the 
previously described working models. Given the our current data set, this framework is unable to capture 
the behavior of this library (data not shown) because the CRX binding sites have the ability to at as 
activating or repressing sites depending on the context. This framework assumes every TFBS behaves in 
a consistent regulatory manner. In order to model this behavior we would need to add major assumptions 
to the thermodynamic framework, and before we add these assumptions we need more information about 
the mechanism of CRX repression.  
In order to constrain quantitative models and to understand the TFBS grammar that underlies 
these complex expression patterns, we are conducting several experiments and analyses. First, we are 
measuring expression controlled by a library of synthetic CREs upstream of the Hsp68 promoter, rather 
than the Rho proximal promoter. This experiment will tell us if homopolymers of CRX TFBS can repress 
44 
an unrelated promoter element. Second, we are measuring the expression controlled by a library of 
synthetic CREs upstream of a mutated Rho proximal promoter, rather than the wild-type Rho proximal 
promoter. This mutant Rho promoter contains two mutations in the annotated NRL binding site. These 
expression measurements will tell us if CRX repression depends on NRL binding in the proximal 
promoter. Finally, we are adapting ChIP to our synthetic CREs in order to measure the occupancy of CRX 
on the synthetic elements. This experiment will tell us if CRX has higher occupancy when there are more 
CRX binding sites and whether the presence of NRL binding sites increases CRX occupancy.  
We conclude that combinations of TFBS for transcriptional activators can generate diverse gene 
expression patterns and even repress the activity of the proximal promoter alone. We find that 
combinations of CRX and NRL sites drive high expression, suggesting a synergistic interaction between 
the two regulators. We also conclude that CRX is capable of acting as a repressor or an activator, 
depending on the sequence context. CRX sites repress when clustered with other CRX TFBS, but CRX 
sites activate when NRL sites are present. In general, interactions between TFs and the dual regulatory 
capacity of TFs can underlie these complex expression patterns. Further genetic and biochemical 
experiments, paired with the development of quantitative models, will aid in the understanding of the 
sequence features that make this possible. 
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MATERIALS AND METHODS 
 
Synthetic CRE Library Design 
Synthetic CREs are composed of three CRX binding site variants and one NRL binding site. 
Short constant buffer sequences were added to each binding site to maintain the helical spacing when 
binding sites were combined (Table 3.1). Using these 4 TFBS sequences, we computationally generated 
all possible synthetic CREs that contain one, two, or three binding sites in both orientations. We 
computationally generated all possible combinations of synthetic elements with four binding sites (4096 
total) and randomly chose 715 of these. In addition, the CREs were designed so that after cloning, the 
basal promoter alone was a part of the library. 
 
CRE-seq Library Construction 
A pool of 6,500 unique 150-mer oligos was ordered through a limited licensing agreement with 
Agilent Technologies. Oligos were structured as follows: 5’ priming sequence 
(GTAGCGTCTGTCCGTC)/XbaI site/CRE/SphI site/randomly generated sequence/EagI 
site/buffer(ACG)/9 bp barcode/buffer(CGC)/ClaI site/3’ priming sequence (GCAACTACTACTACAG).  
Using this method of synthesis, every oligo must be 150 bp in length so the random sequence length was 
determined for each CRE length. The random sequence is removed in the second cloning step and only 
serves to pad the oligo length for synthesis. Barcode sequences were generated as described 
(Kwasnieski et al. 2012). 
The plasmid library was prepared as described (Kwasnieski et al. 2012), except using primers 
JKP6F and JKP6R (Table 3.S1) and an annealing temperature of 55C. The amplified library product was 
purified on a polyacrylamide gel as described (White et al. 2013). Purified library amplicons were cloned 
into pJK01 (Kwasnieski et al. 2012) using XbaI and ClaI. We prepared DNA from 54,000 colonies to 
generate PL6_1. We then cloned the Rho proximal promoter driving DsRed into PL6_1. A cassette 
containing the Rho promoter fused to DsRed was amplified from pJK01 with primers JKP7F and JKP7R 
(Table 3.S1) and cloned into library PL6_1 by using SphI and EagI, creating library PL6_2. To decrease 
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background in our library, we linearized PL6_2 with HindIII, gel purified the library, and re-circularized to 
create library PL6_3.  
 
Retinal Electroporation 
Electroporations and explant cultures were performed as described (Hsiau et al. 2007) by using 
0.5 µg/mL library PL6_3 as well as 0.5 µg/mL CAG promoter driving GFP for visualization of 
electroporation efficiency (Lee et al. 2010). After 8 d in culture, retinas were washed twice in sterile HBSS 
(Gibco, Life Technologies), and total RNA was extracted by using TRIzol according to manufacturer’s 
instructions (Ambion, Life Technologies). 
 
Preparing Samples for RNA-Seq 
Excess DNA was removed from extracted RNA using the TURBO DNA-free kit (Applied 
Biosystems), following manufacturer’s instructions. First strand cDNA was synthesized from the RNA 
using SuperScript II Reverse Transcriptase (Life Technologies). Both the cDNA samples and the DNA 
from the original plasmid library were prepared for sequencing using a custom protocol as described 
(Kwasnieski et al. 2012). Briefly, we used PCR amplification of the sequence surrounding the barcode in 
the RNA transcript or plasmid using primers JKP3F and JKP3R (Table 3.S1). We then digested the PCR 
product using EagI and EcoRI and ligated Illumina adapter sequences (Kwasnieski et al. 2012) to these 
amplified sequences. Libraries were sequenced using the Illumina HiSeq platform. Reads that perfectly 
matched the first 13 expected nucleotides were counted, regardless of quality score. This resulted in 77.5 
million reads from the cDNA, across 4 biological replicates, and 34.8 million reads from the DNA. Only 
barcodes with >=50 reads in the DNA pool and >=3 reads in the cDNA pool were used for downstream 
analysis. The expression of each barcode was calculated as (cDNA reads)/(DNA reads) and then 
normalized to the expression of the basal promoter alone. The expression of each CRE was calculated as 
the mean of the expression of each BC associated with it. 
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Figure 3.1 
 
Figure 3.1 Synthetic CREs have strong and reproducible effects on expression. A) Biological 
replicates of the expression driven by synthetic CREs are highly reproducible. Each dot represents the 
expression controlled of a single CRE. Blue line is the best fit (R2=0.99). B) Every length of synthetic 
elements controls a range of expression levels.  Histogram shows CRE expression (log 2) normalized to 
the expression of the basal Rho promoter alone. Dotted line is expression that is identical to the basal 
promoter. Panels separate CREs by length, or number of component TFBS.  
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Figure 3.2 
 
Figure 3.2 Synergistic regulation of CRX1 and NRL binding sites. Synthetic CREs with both CRX1 
and NRL binding sites drive significantly higher expression than synthetic CREs with only CRX1 or NRL 
binding sites. X-axis lists component TFBS, regardless of order and orientation.  Y-axis measures CRE 
expression. A) Synthetic CREs with two TFBS. B) Synthetic CREs with three TFBS.  
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Figure 3.3 
 
 
Figure 3.3 Synthetic CREs with many CRX binding sites repress the basal promoter. A) Synthetic 
CREs composed of many CRX sites drive low expression and can even repress the basal promoter.  
Boxplot shows CRE-seq expression (log 2 scale) separated by the number of CRX1, CRX2, and CRX3 
TFBS in each CRE.  B) CRX1 homopolymers can repress the basal promoter level. Adding NRL binding 
sites increases total expression but does not counteract the trend that adding CRX1 sites decreases 
expression. Boxplot shows CRE-seq expression (log 2 scale) driven by synthetic CREs that are only 
composed of CRX1 and NRL TFBS. X-axis denotes the number of CRX1 and NRL TFBS in each CRE.   
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Figure 3.4 
 
Figure 3.4 Synthetic CREs display CRX-dependent repression but only in the absence of NRL 
TFBS. Scatterplot compares expression driven by synthetic CREs in the wild-type (x-axis) and the CRX 
null (y-axis) mouse retinas. Each dot represents the expression controlled by a single CRE. Panels 
separate expression by the number of CRX1, CRX2, and CRX3 TFBS in each CRE. Dot color denotes 
number of NRL TFBS in each CRE. 
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Table 3.1 
CRX1 GCTAATCCCA 
CRX2 GCTAAGCCAA 
CRX3 GCTGATTCAA 
NRL GACTGCTGACTCAGCATCA 
 
Table 3.1 Sequences of binding sites that were used in this study. 
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SUPPLEMENTARY FIGURES AND TABLES 
Table 3.S1 
JKP3F TGTTCCTGTAGCGGCCGACG 
JKP3R GAATTCTAGCCAGAAGTCAGATGCTCAAG 
JKP6F GTAGCGTCTGTCCGTCTCTAG 
JKP6R CTGTAGTAGTAGTTGCATCGATG 
JKP7F TAGCATGCATGTCACCTTGGCCCCTC 
JKP7R GGCCATCGATCTCGAGTAAC 
JKP8F TCTCTAGACTCCTCCGGCTCGCTGATTG 
JKP8R CAGGTACCCCATGGCGCCGCGCTC 
JKP9F TAGCATGCCTCCTCCGGCTCGCTG 
JKP9R AGCCTGCACCTGAGGAGT 
 
Table 3.S1 Primer sequences used in this study. 
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Figure 3.S1 
 
Figure 3.S1 Synthetic CREs with many NRL binding sites drive low expression. Synthetic CREs 
composed of many NRL TFBS drive low expression.  Boxplot shows CRE-seq expression (log 2 scale) 
separated by the number of NRL TFBS in each CRE.   
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Figure 3.S2 
 
Figure 3.S2 Synthetic CREs control similar expression levels in two wild-type mouse 
backgrounds. Comparison of expression driven by synthetic CREs in wild-type B6 (x-axis) and wild-type 
CD (y-axis) mice backgrounds shows high correlation (R2=0.96).  
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CHAPTER 4: DISCUSSION 
 
There are three main aims of my thesis: to develop a high-throughput multiplexed reporter assay 
technique, to use this method to understand how nucleotides contribute to the control of gene expression, 
and to use this method to understand how combinations of transcription factor binding sites (TFBS) 
regulate expression. Toward the first aim, I developed a method for cis-regulatory element (CRE) 
sequencing (CRE-seq) that allows high throughput construction and assay of thousands of CREs in a 
single experiment.  This method produces reproducible gene expression measurements that have a high 
correlation with traditional reporter assay measurements.  Toward the second aim, I utilized this method 
to understand the impact of each nucleotide in the Rhodopsin (Rho) promoter.  I found that most single 
nucleotide variants have a significant impact on gene expression levels and that most combinations of 
variants drive expression that is not an additive sum of the single variant expression levels.  Toward the 
third aim, I tested combinations of CRX and NRL TFBS to understand how they drive expression.  I found 
that seemingly simple synthetic CREs generated diverse expression levels due to dual regulation and TF 
synergy.  These findings have broad impacts for the study of mammalian cis-regulation, as I discuss 
below. 
 
Comparison of Methods for High Throughput Reporter Analysis 
Early methods for high throughput reporter analysis used in vitro transcription (Patwardhan et al. 
2009) or quantitative PCR (q-PCR) for expression measurement (Nam et al. 2010).  Our CRE-seq 
method was published along side several other studies (Melnikov et al. 2012; Patwardhan et al. 2012; 
Sharon et al. 2012; Arnold et al. 2013) developing similar methods. All of these methods multiplex 
reporter gene expression measurements by barcoding the reporter gene 3’ UTR, but each has 
differences, mainly in the process of library construction. Here I compare the methods that multiplex 
reporter expression measurements in eukaryotic cells with next-generation sequencing.  
  Two of these methods utilize random construction strategies so they do not have limitations on 
CRE length or library complexity.  First, in the Starr-seq (Arnold et al. 2013) method the enhancer 
sequence is cloned into the 3’ UTR and it serves as the CRE as well as the barcode. Studies have shown 
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that 3’ UTR sequences can have large effects on gene expression outside of transcriptional control 
(Shalem et al. 2013), so the accuracy of Starr-seq approach is limited.  
Second, In the Massively Parallel Functional Dissection (MPFD) (Patwardhan et al. 2012) 
method, stitching PCR and random library construction is paired with a PCR-based subassembly method 
to match CRE and barcode sequences. Expression is calculated as the fraction of biological replicates 
where a barcoded mRNA is detected, which is in contrast to most other methods that use the abundance 
of barcoded mRNA. Published uses of this method have measured expression from very complex library 
pools, which require large amounts of sequencing coverage and are therefore expensive.   
Two other methods use array-based oligo synthesis for library construction, as does CRE-seq. 
This approach is advantageous because it allows construction of a high fidelity CRE library with 
systematically designed sequence derivatives. First, the Massively Parallel Reporter Assay (MPRA) 
(Melnikov et al. 2012) method is most similar to CRE-seq. The main difference between MPRA and CRE-
seq is that MPRA sequences DNA barcodes from the original plasmid pool, rather than from the 
transfected cells.  Our work has shown these approaches result in similar DNA counts and therefore we 
have switched to sequencing the plasmid pool to reduce sequencing costs.  
Second, the Segal lab (Sharon et al. 2012) method measures fluorescence, separates cells 
based on expression, and sequences barcodes from the binned pools.  Expression is calculated as the 
abundance in each expression pool, which results in a more course-grained measurement of gene 
expression than the other methods.  
Taken together, these methods primarily differ in library construction strategies, which allows the 
user to choose a method based on CRE design constraints. In particular, measuring the abundance of 
mRNA barcodes is very quantitative and I recommend methods that take advantage of this.  Potential 
improvements to CRE-seq could include the integration of the reporter gene constructs the genome, or 
the potential to read out spatial or temporal expression patterns with the method.   
 
Potential Improvements to CRE-seq  
The limitations of this technology are twofold: the plasmid expression system is transient and 
CRE-seq does not currently support the measurement of temporal and spatial expression patterns. 
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Technique improvements could address these issues. Currently, the number of divisions that the 
transfected cell population undergoes can limit the duration of CRE-seq experiments because the plasmid 
library is diluted in the cell population.  Integrating the CRE-seq libraries with lentiviral transduction or 
CRISPR editing technologies would allow expression profiling in a stable cell population, expanding the 
number of tissues amenable to CRE-seq analysis.  Genes are expressed in temporal and spatial patterns 
that are important for appropriate cell function but current CRE-seq methodology can only measure 
expression from a homogeneous cell population.  Harvesting RNA across different time points or isolating 
single cell RNA with laser capture micro-dissection would allow CRE-seq to measure expression in 
relevant temporal and spatial patterns. 
 
Phenotypic Interpretation of Mutagenesis Study 
In Chapter 2, we found that most sequence variants have a significant impact on expression.  
This result is surprising because nearly all mutations, even those located in sequences that are not 
thought to bind a TF, drove expression that was significantly different than wild-type expression. In 
addition, we concluded that combinations of these variants drove expression that was not accurately 
predicted from single variant expression levels.  Together, these results imply that for non-coding 
variation in promoter sequences, most variants will have functional consequences for expression control, 
and many of these variant combinations will generate non-additive expression levels.  
To my knowledge, no other studies have examined the activity of a mammalian promoter in such 
detail. We know that Rho is a highly expressed gene and its precise expression is critical for homeostasis 
of the retina. It is possible that this promoter is precisely tuned so that correct activity is easily disrupted. 
Two studies (Melnikov et al. 2012; Patwardhan et al. 2012) have tested the impact of enhancer variants 
on gene expression and found that few sequence variants drove significantly different expression than 
wild-type levels. There are several biological reasons to explain the differences in these results; technical 
reasons are discussed in Chapter 2.  First, sequence variants in enhancers may be less likely to disrupt 
gene expression control than sequence variants located in promoter sequences.  Second, the activity of 
these specific enhancers may be less affected by sequence variants than the activity of the Rho 
promoter.  Third, it may be that this reporter assay design, where all regulatory sequences are cloned 
58 
fewer than 500 base pairs upstream of the transcription start site, is more sensitive to expression 
changes in promoters than enhancers.  To further test these ideas, one could use CRE-seq to examine 
the impact of sequence variants on enhancer activity.  
The conclusion that most variants significantly impact expression is based on the results of 
statistical tests that determined mutant expression measurements were significantly different than wild-
type expression levels.  A large fraction of variants drove significantly different mean levels of expression, 
but it was not clear whether this number of significant changes was more or less than expected. There is 
no established null model for predicting how regulatory sequence activity changes upon mutation. To 
develop a null model that describes the frequency that of variants that impact expression, one could 
conduct a similar study, but compare expression of random genomic sequences against their mutated 
versions. The results of this experiment would further develop our understanding of how sequence 
variants impact expression control. 
It is clear from this mutagenesis study that sequence variants in the Rho promoter can have large 
effects on the expression level of the gene.  Future work should characterize these sequence variants in 
the context of other genomic elements and at a phenotypic level.  We see large expression changes 
when the mutated promoter drives expression in isolation, but in the mouse genome there are many 
regulatory elements that control expression of the Rho gene.  Experiments to measure the expression 
changes of these promoter mutations in the Rho locus would develop our understanding of whether 
sequence variants are buffered in a genomic context. We observed sequence variants that control 
expression 60-fold lower than wild-type levels and I hypothesize this Rho dysregulation would be 
sufficient to induce a phenotype. Experiments to generate transgenic mice with single Rho promoter 
mutations and assay the transgenic retinas for structure and function would answer this question. These 
experiments will help us understand how expression studies of isolated genomic elements can translate 
into interpretation of the impact of human non-coding variation. 
This study is one of the first detailed examinations of how sequence variants impact the activity of 
a mammalian promoter.  It demonstrates that mammalian promoters are precisely tuned and therefore 
subject to significant expression changes upon mutation.  These results imply that human non-coding 
variation in promoter sequences will likely have functional consequences for gene expression control. 
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Complex Expression Controlled by Simple cis-Regulatory Elements 
In Chapter 3, I discussed our work to understand how combinations of TFBS control expression.  
The main conclusion of this study is that simple regulatory elements, only containing TFBS for 
transcription activators, generate diverse expression levels. These simple elements can drive expression 
levels that are activated above the basal promoter and expression levels that are repressed below the 
basal promoter. This result motivates the continued study of cis-regulation in controlled model systems 
where annotated transcriptional regulators have measured binding specificity because we are surprised 
by the complexity in expression that is controlled by simple regulatory elements. 
Synthetic regulatory elements provide a useful paradigm for the study of cis-regulation because 
they allow TFBS interrogation while minimizing the number of confounding variables. The simplicity of 
these reporter constructs allows for the detection of cis-regulatory patterns but it can also limit the study.  
For example, if TFs are regulating synthetic CREs differently than genomic CREs, due to the design of 
synthetic CREs, discovered patterns may not be useful in studying genomic CREs.  Developing a hybrid 
approach where one may study the expression controlled by CREs that are rooted in genomic sequences 
but have synthetic attributes, would allow for statistical power while maintaining relevant CRE design. 
This might include genomic sequences where TFBS identity and/or orientation are swapped. The results 
of this experiment would continue to build our understanding of how TFBS control expression, but easily 
translate into conclusions about genomic elements. 
This work contributes to the study of cis-regulation in the mammalian rod photoreceptor cell 
because we have learned new principles that govern how combinations of NRL and CRX binding sites 
regulate gene expression. Future work, as discussed in Chapter 3, will generate data for the development 
of a quantitative framework. This model will be used to describe regulation by CRX and NRL, and this 
model will improve expression predictions for rod-cell specific genes. 
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APPENDIX 1: MASSIVELY PARALLEL SYNTHETIC PROMOTER ASSAYS REVEAL THE IN VIVO 
EFFECTS OF BINDING SITE VARIANTS 
Ilaria Mogno1, Jamie C. Kwasnieski1, and Barak A. Cohen 
 
1These authors contributed equally to this work 
Center for Genome Sciences and Systems Biology, Department of Genetics, Washington University 
School of Medicine in St. Louis, MO, 63108 
 
 This work was done in collaboration with Ilaria Mogno and Barak Cohen. Ilaria Mogno, Barak 
Cohen and I conceived the project and designed experiments.  Ilaria Mogno and I performed the 
experiments and Ilaria Mogno did the data analysis.  Ilaria Mogno, Barak Cohen and I wrote the paper. 
This chapter is a manuscript published in 2013 in the journal Genome Research.  
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ABSTRACT 
Gene promoters typically contain multiple transcription factor binding sites (TFBS), which may vary in 
affinity for their cognate transcription factors (TF).  One major challenge in studying cis-regulation is to 
understand how TFBS variants affect gene expression. We studied the in vivo effects of TFBS variants on 
cis-regulation using synthetic promoters coupled with a thermodynamic model of TF binding. We 
measured expression driven by each promoter with RNA-seq of transcribed sequence barcodes. This 
allowed reporter genes to be highly multiplexed and increased our statistical power to detect the effects of 
TFBS variants. We analyzed the effects of TFBS variants using a thermodynamic framework that models 
both TF-DNA interactions and TF-TF interactions. We found that this system accurately estimates the in 
vivo relative affinities of TFBS and predicts unexpected interactions between several TFBS. Our results 
reveal that binding site variants can have complex effects on gene expression due to differences in TFBS 
affinity for cognate TFs and differences in TFBS specificity for non-cognate TFs. 
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INTRODUCTION 
Transcription factors (TFs) orchestrate programs of gene expression by binding promoters and 
interacting with the core transcriptional machinery.  Promoters typically contain multiple transcription 
factor binding sites (TFBS) with varying affinities for their cognate TFs.  Analyses of TFBS variants must 
account for the effects of low affinity sites, which often have important and surprising roles in gene 
regulation, especially when TFs bind cooperatively (Driever et al. 1989; Jiang and Levine 1993; Wharton 
et al. 2004; Gertz et al. 2009; Parker et al. 2011; Peterson et al. 2012).  Position weight matrix (PWM) 
models (Stormo 2000) of binding affinities facilitate the study of TFBS variants; however, these models 
are often developed in vitro and offer a limited picture of the in vivo effects of variants on gene 
expression. The effect of a TFBS variant on gene expression is a function of the sum of its effects on 
binding by, potentially all, other TFs present in the nucleus. In support of this model, recent genome-wide 
binding studies show a striking overlap of TF binding profiles (Neph et al. 2012). Therefore, given all the 
possible interactions between TFs and between TFs and DNA, it is difficult to model and predict the in 
vivo effects of TFBS variants. The analysis of TFBS variants is particularly relevant in light of studies of 
human genetic variation (Abecasis et al. 2012) and the role of non-coding polymorphisms in complex 
traits and disease (Degner et al. 2012; Maurano et al. 2012). Progress in this field requires methods to 
study the effects of combinations of TFBS variants inside cells.    
Synthetic promoters are powerful tools for studying cis-regulation (Cox et al. 2007; Gertz and 
Cohen 2009; Gertz et al. 2009; Mogno et al. 2010; Raveh-Sadka et al. 2012). Recent advances in DNA 
synthesis and high-throughput sequencing have driven the development of novel techniques for 
measuring large numbers of synthetic promoters (Kwasnieski et al. 2012; Melnikov et al. 2012; 
Patwardhan et al. 2012; Sharon et al. 2012; Arnold et al. 2013). These techniques add transcribed 
sequence barcodes to traditional fluorescent reporter genes, allowing reporter genes to be highly 
multiplexed and assayed by RNA-seq. To date, all of these methods rely on plasmid-based reporter gene 
libraries.  Limitations in the length of synthesized DNA restrict some of these techniques to assaying 
relatively short synthetic regulatory elements.  Here we present a method to assay large numbers of 
chromosomally-integrated synthetic promoters of arbitrary size. We implemented the method in the yeast 
S. cerevisiae and used it to study the effects of TFBS variants on cis-regulation. 
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The method we developed is a variant of CRE-seq (Kwasnieski et al. 2012), a technique created 
to transiently assay large numbers of cis-regulatory elements in mammalian cells. The modifications we 
made to this technique allow us to sample large numbers of chromosomally-integrated synthetic 
promoters consisting of combinations of TFBS with differing affinity. This large sampling was necessary to 
obtain the statistical power necessary to model the effects of TFBS variants on cis-regulation.  We fit a 
thermodynamic model to the resulting data, which provides a formal framework to describe the system in 
terms of TF binding to DNA, and interactions between TFs. We found that binding site variants have 
complex effects on gene expression that are due to both differences in affinity for their cognate TFs, and 
differences in specificity for non-cognate TFs.  
 
RESULTS 
 
Construction Of A Barcoded Synthetic Promoter Library 
We sought to understand how sequence variants of TFBSs affect gene expression. We 
previously used libraries of fluorescent reporter genes to study cis-regulatory interactions between four 
TFBSs, which correspond to binding sites for Mig1, Reb1, Rap1, and Gcr1 (Gertz et al. 2009; Mogno et 
al.). To build on our previous results with consensus TFBS, we chose to create libraries consisting of 
variants of these same four sites.  For each of the four TFs we chose three variants, with differing 
predicted affinity, for a total of twelve TFBS (e.g. Mig11, Mig12, and Mig13 denote three variants of the 
Mig1 TFBS).  Table A1.1 shows the specific sequences we chose and the estimated affinities to their 
cognate TFs as calculated with a position weight matrix (PWM) model (Stormo and Fields 1998; 
MacIsaac et al. 2006) based on ChIP data (Harbison et al. 2004). We tested TFBS with a wide variety of 
predicted affinities, from very high (Mig11), to very low predicted affinity (Reb13 and Rap12). Because the 
increase from four to twelve TFBSs entails an exponential increase of the number of possible synthetic 
cis-regulatory elements (CREs), we implemented CRE-seq technology to multiplex our expression 
measurements. 
We built a CRE-seq reporter library in which each synthetic CRE reporter gene contained a 
unique sequence barcode in its 3’ UTR.  We first synthesized double-stranded oligonucleotides (oligos) 
corresponding to each of the three TFBS variants for each TF: Mig1, Reb1, Rap1 and Gcr1 (Table A1.1). 
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These oligos were pooled and then randomly ligated to form a library of synthetic CREs (Figure A1.1 
panel A, Supplementary Figure A1.S1), which was cloned into a plasmid. We then inserted a library of 
random fifteen nucleotide barcodes downstream of the CREs, such that each barcode uniquely identified 
a specific CRE.  We performed this cloning step in such a way that each CRE was attached to more than 
one unique barcode: our final library contained 7289 BCs representing 2534 unique CREs 
(Supplementary Figure A1.S2). This redundancy increases our statistical power by providing multiple 
expression readouts for any specific CRE.  
We matched the barcodes to their specific CRE using paired-end sequencing of the plasmid 
library containing the CREs and barcodes (Figure A1.1 panel B, Supplementary Figure A1.S1), coupled 
with a naïve clustering algorithm (Methods). We were careful not to use PCR to prepare the library for 
sequencing as we found that PCR amplification creates chimeric products that scramble the CRE-
barcode associations.  After determining the CRE-barcode associations we cloned a cassette containing 
a basal promoter (TSA1) driving Yellow Fluorescent Protein (YFP) into the library, between the CREs and 
the barcodes. The entire library cassette was then excised and inserted into the S. cerevisiae genome at 
the TRP1 locus (Figure A1.1 panel C). 
 To measure, in parallel, the expression driven by each CRE, we grew the integrated yeast 
library, and then sequenced the barcodes from harvested RNA and genomic DNA (gDNA). We computed 
the cDNA/gDNA ratio of each barcode and used the median ratio for all barcodes corresponding to a 
particular CRE as the expression of that CRE.  
 
CRE-Seq Accurately Measures Gene Expression  
To test the accuracy of the CRE-seq method in S. cerevisiae, we compared expression 
measurements made by CRE-seq to those made by flow cytometry. We picked 337 CREs containing 
sites for Mig11, Reb11, Rap11 and Gcr11 and measured their expression in glucose minimal media by flow 
cytometry. We then pooled all strains and measured their expression in glucose minimal media by CRE-
seq. The high correlation (r=0.92) between pooled CRE-seq measurements and individual flow cytometer 
measurements confirms that CRE-seq accurately measures gene expression in our system (Figure A1.2 
panel A).  
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To verify that the fifteen base pair barcodes in the 3’UTR of the reporter genes do not affect our 
measurements, we assayed the effects of barcode sequences on expression.  Using CRE-seq we 
assayed the expression of 602 clones of the same promoter, in which each clone contained a different 
barcode sequence in its 3’ UTR. We performed two replicates of this experiment. If the barcodes have an 
effect on gene expression we expect to see a positive correlation between the two replicates, as 
barcodes that increased reporter expression would be correlated between replicates. However, we 
observed a low correlation between the two replicates (r=0.04). The lack of correlation demonstrates that 
the random barcodes in the 3’UTR do not have reproducible effects on expression (Figure A1.2 panel B).  
 
Model Selection 
After verifying the accuracy of our assay, we analyzed the full library, composed of 7289 BCs for 
2534 CREs. To understand the rules of combinatorial regulation we applied a thermodynamic model to 
our data. This model is a formal framework that describes the data in terms of TF binding to DNA, and 
interactions between TFs, and provides an automated method to detect the effects of TFBS in large sets 
of promoters (Gertz and Cohen 2009; Gertz et al. 2009; Mogno et al. 2010).  Because the differences in 
expression between members of our library were not correlated with predicted nucleosome occupancy 
(R2=0.033), we did not explicitly model interactions with nucleosomes (Kaplan et al. 2009).  
We first analyzed CREs containing only Mig11, Reb11, Rap11, and Gcr11 sites, and recapitulated 
the results in (Gertz et al. 2009; Mogno et al. 2010) (Supplementary Table A1.S1), showing that Mig11 
sites act cooperatively to repress expression, while the Reb11, Rap11, and Gcr11 sites all have activating 
effects. We therefore demonstrated that the trends in expression data from CRE-seq recapitulate the 
trends in expression measured by traditional reporter gene assays.  
To explore different potential mechanisms that could account for the effects of TFBS variants we 
applied several thermodynamic architectures to the full data set with all twelve TFBSs. We started with 
the simplest set of hypotheses: each TF binds at its three cognate TFBS with different affinities (Figure 
A1.3 panel A). We also included a parameter to represent the Mig1-Mig1 cooperative interaction that was 
found in Gertz et al (Gertz et al. 2009) and verified in our data.  
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We then asked whether our data supported a model with additional interactions. We started by 
generating a list of additional features (hypotheses) that were not present in the initial simple model, 
including: 1) an interaction term between Rap1 and Gcr1, as suggested by (Scott and Baker 1993; 
Tornow et al. 1993), 2) a cooperativity term for Gcr1, as suggested by our expression data 
(Supplementary Figure A1.S3) and by (Scott and Baker 1993), 3) a term allowing a protein (X) other than 
Reb1 to bind the Reb13 site, and 4) a term allowing a protein (Y) other than Rap1 to bind the Rap12 site. 
We included features 3) and 4) because Reb13 and Rap12 had strong effects on expression even though 
PWM analysis of these sites indicates that they have very low affinities for their TFs, which suggests that 
their effects may be mediated through the binding of other TFs.   
After identifying a set of features that might improve the simple model, we constructed several 
model architectures including these additional features in various combinations. Each model was fit to the 
measured expression values and scored based on the sum of squares of the residuals (RSS) and the 
number of free parameters needed for the fit, introducing a greater penalty for models with more free 
parameters. When we rank our models based on this score, a clear pattern appears (Figure A1.4 panel 
A): the addition of the Rap1-Gcr1 interaction consistently lowers the model score (worse model), while 
adding Gcr1 cooperativity always results in a higher score (better model). Moreover, allowing unknown 
proteins to bind the Reb13 and Rap12 sites (6 TFs in total), results in a better model even after 
penalization for increased parameter number.  The best performing model includes parameters 
representing Mig1 self-cooperativity, Gcr1 self-cooperativity, a protein (X) other than Reb1 binding at site 
Reb13, and a protein (Y) other that Rap1 binding at site Rap12 (Figure A1.3 panel B). Scoring Reb13 and 
Rap12 against PWMs for known TFs (Spivak and Stormo 2012) suggests that Reb13 may be bound by 
Rtg1 (p= 0.0032) and that Rap12 may be bound by Yer130C (p=0.0059). This result is not surprising 
given that the PWM models for these two sites (Reb13 and Rap12) predicted extremely low affinity for 
their cognate TFs (see Table A1.1). It is therefore reasonable to expect other TFs to bind to these 
particular sites.  
This model explains 57% (p<<0.01) of all the variance in expression in our twelve-site synthetic 
promoter library (Figure A1.4 panel B). We performed repeated random sub-sampling validation 
(Supplemental Figure A1.S5), showing that we obtain similar results with approximately 1000 unique 
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promoters. However, to obtain reliable estimates of some parameters, at least 2000 unique promoters are 
necessary.  Thus, the extra statistical power afforded by CRE-seq allowed us to identify features of this 
system that were undetectable in our previous experiments with smaller libraries (Gertz and Cohen 2009; 
Gertz et al. 2009; Mogno et al. 2010). 
 
The Thermodynamic Model Predicts In Vivo Relative Affinities Between Tfs and DNA 
We next asked whether the in vivo predicted affinities estimated from our thermodynamic model 
match the PWM predictions from ChIP-seq data. We computed DDG for pairs of binding sites. A negative 
DDG indicates a stronger TFBS (with higher affinity), while a positive DDG indicates a weaker site. When 
the PWM and our thermodynamic model are in agreement, the DDG calculated with the PWM and the 
DDG calculated with the thermodynamic model are proportional. For example, our model is in good 
agreement with the PWM model for Mig1 (Table A1.2, rows 1 and 2).  Our model also agrees with PWM 
predictions that Rap13 is stronger than Rap11 (Table A1.2, row 3). In contrast, our model predicts Reb12 
to be stronger than Reb11, while the PWM model predicts the opposite (Table A1.2, row 4).  
Our relative affinity predictions for Gcr1 do not agree with PWM models (Table A1.2, rows 5 and 
6). Our model predicts that Gcr12 is the strongest site for Gcr1, while the PWM model predicts Gcr13 to be 
the strongest site. The PWM model was generated using genome-wide chromatin immunoprecipitation 
(ChIP) data collected in a rich media (Harbison et al. 2004; MacIsaac et al. 2006); our predictions are 
estimated from measuring synthetic promoter expression in minimal media. It is possible that the 
inconsistencies in these predictions can be explained by differences in growing conditions or by 
differences between measuring binding versus activity through a gene expression based reporter assay.  
We also tried using different PWM models for Gcr1, which came from different experiments.  None of 
these PWMs for Gcr1 are in good agreement with each other, nor do they agree well with our predictions 
(Harbison et al. 2004; MacIsaac et al. 2006; Pachkov et al. 2007; Foat et al. 2008; Spivak and Stormo 
2012). The relationship between occupancy at the Gcr1 sites and the sites’ effect on gene expression 
may be complicated by condition-specific binding of Gcr1, or the binding of other factors. In the following 
analysis, we refer to Gcr12 as the strongest site and Gcr11 as the weakest site, as predicted by our 
model.  
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Gcr1 Participates In Complex TF-TF Interactions 
The Gcr1 binding sites used in this study showed the ability to enhance the activity of surrounding 
TFBS, regardless of whether activators or repressors bind to those TFBSs. When Gcr11 sites are added 
to promoters containing only Mig11 sites, their average expression decreases (Figure A1.5, panel A). In 
contrast, when Gcr11 sites are added to promoters containing only Reb11 or Rap11 sites, the expression 
of the reporter gene increases. We also observe a similar behavior when Gcr11 is added to Reb12, Reb13, 
Rap12 and Rap13. However, the ability of Gcr11 to repress is weaker when it is coupled with weaker sites 
for Mig1 (e.g. Mig12 and Mig13, 5, panel B). The data suggest that the Gcr11 site acts as an activator 
when next to any activator site, but it acts as a repressor when next to a strong Mig1 site, and has little 
effect next to a weak Mig1 site. Increasing the predicted affinity of the Gcr1 site hides this behavior: 
Gcr13, a stronger site, has a smaller effect on Mig11 site (Figure A1.5, panel C). The repressing effect 
disappears when we use Gcr12, the highest affinity site. Moreover, this effect is particularly strong in 
promoters in which Gcr11 and Mig11 sites are adjacent to each other (Supplementary Figure A1.S4). 
These data seem to suggest a role of the Gcr1 sites in facilitating the binding of other TFs, and increasing 
their regulatory potential.  
 
DISCUSSION 
We adapted CRE-seq for use with synthetic promoters of arbitrary size integrated into the 
genome of S. cerevisiae. With the development of CRE-seq we can assay thousands of integrated 
synthetic promoters, a 10-fold increase over what was previously possible with fluorescent reporter 
genes. We showed that the method is accurate and reproducible, and that the barcodes in the 3’ UTR of 
the reporter gene do not affect gene expression. As technologies for genome editing (Christian et al. 
2010; Bogdanove and Voytas 2011) become more efficient, we anticipate using CRE-seq to study 
synthetic promoters integrated into the genomes of mammalian cells. 
An advantage of CRE-seq is that it allows us to build larger libraries, since all clones are built and 
assayed in parallel. It also overcomes some of the limitations of traditional assays based on flow 
cytometry, such as limited dynamic range. CRE-seq measures the abundance of mRNA rather than 
stable fluorescent proteins, whose long half-lives could mask the true promoter activity.  
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We used CRE-seq to obtain the statistical power necessary to study cis-regulation in promoters 
containing combinations of TFBS variants. The increased power we obtained from analyzing large 
libraries revealed TFBS effects that we could not detect in smaller libraries composed of the same binding 
sites. This demonstrates the utility of CRE-seq when applied to synthetic promotes. In many cases our 
binding affinity predictions agree well with established PWM models of binding (MacIsaac et al. 2006). In 
cases where our predictions were discordant with PWM predictions, as was the case for Reb13 and 
Rap12, we found that our data supported a model in which these variant TFBSs are recognized by other 
TFs. We think the differences in these predictions stem from different experimental conditions and the 
fact that in vitro binding is not equivalent to in vivo expression potential. 
Our work uncovered an unusual interaction between Gcr1 and Mig1. Although Gcr1 sites behave 
as weak activators, when put in combination with repressive Mig1 sites, Gcr1 sites increase the 
repressive effects of Mig1. One possible explanation is that Gcr1 binding opens the locus, thus facilitating 
the binding of Mig1. This manifests as a greater repressive effect of Mig1, but only when the activating 
potential of Gcr1 is weak. 
With the increasing power and affordability of next generation sequencing technologies, we 
anticipate that CRE-seq will be a useful tool for unraveling other kinds of interactions between cis-
regulatory sequences.  
 
ACKNOWLEDGEMENTS 
We thank Chris Fiore and Robi Mitra for discussions on the CRE-seq technical details; Aaron 
Spivak for assistance with PWM analysis; Jessica Hoisington-Lopez, Henning Seedorf, Michelle Smith, 
Brian Muegge and Jeffrey Gordon for next-generation sequencing support. This work was supported by a 
grant from the National Institutes of Health (GM092910-02). 
  
  
70 
MATERIALS AND METHODS 
 
Construction of the CRE-BC Library 
 E. coli strain DH5a was used for all bacterial cloning steps. Plasmid pIM202 was derived from 
pIM102 (Mogno et al. 2010) by removing the TSA1 promoter-YFP cassette and replacing it with a multiple 
cloning site (containing sites for BglII, XmaI, BamHI, KpnI, ClaI, EagI, AvrII and XbaI restriction enzymes).  
CREs were cloned into pIM202 at the BamHI site as in (Gertz and Cohen 2009; Gertz et al. 2009; Mogno 
et al. 2010), and approximately 7000 colonies were scraped for DNA extraction using a maxiprep kit 
(Sigma GenElute HP Plasmid Maxiprep Kit).  
 To create random barcodes two oligos containing 15 random nucleotides flanked by 6 or 7 bases 
(oligos prIM01 and prIM02, Supplementary Table A1.S2), were denatured at 95C in a water bath and 
then annealed for 16 hours until the water reached room temperature. The BCs were then cloned into the 
CRE plasmid library using restriction sites EagI HF and XbaI. The ligations were digested with AvrII 
before transformation to reduce background. Roughly 20000 colonies were then scraped and 
maxiprepped (Sigma GenElute HP Plasmid Maxiprep Kit) at this step. The TSA1 promoter-YFP cassette 
was amplified from plasmid pIM102 (98°C for 1min, 5 cycles: 98°C for 15s, 56°C for 30s, 72°C for 60s, 25 
cycles: 98°C for 15s, 63°C for 30s, 72°C for 60s, and 72°C for 5 min, NEB HF Phusion MM) using primers 
prIM03 and prIM04 (Supplementary Table A1.S2) and cloned into the library using restriction enzymes 
KpnI and EagI HF. The ligation mix was digested ClaI after ligation to reduce background. About 35000 
colonies were picked at this step. The CRE-BC plasmid library was integrated into S. cerevisiae BY4742 
(MATa his3D1 leu2D0 lys2D0 ura3D0) at the TRP1 locus following the procedure described in (Gertz and 
Cohen 2009; Gertz et al. 2009; Mogno et al. 2010). Between 7000 and 8000 S. cerevisiae colonies were 
replicated into SC media with 2% glucose and 5-FAA (5-Fluoroanthranilic acid) to enrich for the colonies 
carrying the correct integration. These colonies were scraped and pooled for growth and expression 
assays.  
 
Matching CREs to BCs 
 CREs and BCs were matched after cloning the BCs into the plasmid library but before inserting the 
71 
TSA1 promoter -YFP cassette. The plasmid library was digested with restriction enzymes XmaI and XbaI. 
Illumina paired end adaptors were ligated, and the DNA molecules between 250 and 500 base pairs in 
length were selected on agarose gel. No PCR was performed to prevent chimeric products that mask the 
correct CRE-BC pairs. The purified DNA was then sequenced with an Illumina MiSeq using a paired-end 
250x50bp protocol to sequence the CRE and BC regions respectively. We obtained about 1 million reads. 
BCs represented by fewer than 5 reads were not used in the analysis. Occasionally, more than one CRE 
was associated with a particular BC. In this case the CRE with the highest number of reads was assigned 
to the BC if and only if it was represented by at least 90% of the total number of reads associated to the 
BC. Otherwise the BC was not included in our analysis. Subsequently, all BCs associated to the same 
CRE were analyzed. We calculated the pairwise sequence distance for all BCs representing the same 
CRE and we eliminated the ones that had similar sequences to another BC of higher rank, assuming that 
they arise from sequencing errors. 
 
Flow Cytometer Assay 
The strains used for the validation experiment, (Figure A1.2 panel A) were picked from the 
transformation plate and arrayed into 96 well microplates. The CREs and the BCs were sequenced with a 
Sanger protocol (Beckman Coulter Genomics). Cultures were grown in 500 ml of synthetic complete 
media lacking uracil with 2% glucose with shaking at 30°C in 2 ml 96-well plates for four hours. The cells 
were then fixed with paraformaldehyde as described in (Gertz and Cohen 2009; Gertz et al. 2009; Mogno 
et al. 2010). The fluorescence intensities and electronic volumes of 25000 cells from each well were 
measured on a Beckman Coulter Cell Lab Quanta SC with a multi-plate loader. Fluorescence was then 
divided by volume to obtain a normalized fluorescence value for every cell. For each well, mean and 
variance were calculated from the normalized fluorescence values for 25000 events.  
 
CRE-seq 
The S. cerevisiae library was grown in synthetic complete media lacking uracil with 2% glucose 
with shaking at 30°C. After 5 hours gDNA and total RNA were harvested. RNA was then treated with 
Turbo DNaseI (Ambion) to eliminate genomic DNA contamination and cDNA was synthesized using 
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Superscript II reverse transcriptase (Invitrogen), with oligo-dT primers (IDT).  The 3’UTR of the YFP gene, 
containing the BC, was amplified from gDNA and from cDNA (98°C for 1min, 5 cycles: 98°C for 15s, 54°C 
for 30s, 72°C for 45s, 10 cycles: 98°C for 15s, 58°C for 30s, 72°C for 45s, and 72°C for 5 min, NEB HF 
Phusion MM) using primers prIM05 and prIM06 (Supplementary Table A1.S2). We also used primers that 
amplify across the integration region, prIM05 and prIM07 (Supplementary Table A1.S2), on the gDNA to 
select for correct integrations. Only the BCs represented in this second control gDNA PCR were included 
in our analysis. The PCR products were purified with QIAquick PRC purification kit (Qiagen), digested 
with EagI HF and XhoI, and ligated to Illumina adaptor sequences. The final product was amplified (98°C 
for 1min, 12 cycles: 98°C for 15s, 63°C for 30s, 72°C for 45s, and 72°C for 5 min) with primers prIM08 
and prIM09 (Supplementary Table A1.S2) to enrich for molecules containing both adaptors sequences. 
This library was run on two lanes of Illumina HiSeq machine generating approximately 102 million reads. 
Only barcodes with >25 reads in the gDNA pool, and at least one read in the cDNA pool were used for 
the analysis, for a total of 7289 BCs. Expression associated to each BC was then calculated as the 
number of reads in the cDNA pool divided by the number of reads in the gDNA pool (for the same set of 
primers). These 7289 BCs mapped to 2633 unique CREs. Subsequently we determined that 99 of these 
CREs were likely to contain mutations that altered their expression (see Outlier Detection below). The 
distribution of BCs identifying each promoter was uneven, 16.1% of the promoters had at least 3 BCs 
associated with them, while the remaining 83.9% had 2 or fewer (Supplementary Figure A1.S2).  Finally, 
expression driven by each CRE was calculated as the median ratio of all the BCs associated to it.  
 
Thermodynamic Model 
To model gene expression, we implemented a thermodynamic model of polymerase occupancy 
originally proposed by (Shea and Ackers 1985). The model and implementation were described 
previously in (Gertz and Cohen 2009; Gertz et al. 2009; Mogno et al. 2010), and it includes parameters 
proportional to DGs of the interactions between proteins and DNA and between proteins. We did not 
model nucleosome effects. We scanned our promoter sequences with the Nucleosome Positioning 
prediction software (Kaplan et al. 2008), and found very low correlation between predicted nucleosome 
occupancy averaged across the TFBS region and the measured expression (r=0.184). Moreover, the 
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averaged nucleosome occupancy predictions were very similar across our promoter sequences 
(CV=0.06). Akaike Information Criterion (Akaike 1974), which introduces a penalty term for the number of 
parameters, was used for model selection. Repeated random sub-sampling validation was performed for 
cross-validation with training sets containing 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 
and 90% of the total number of data points. All calculations were performed using the Matlab package 
from The Mathworks, Inc. (Natick, MA).  
 
Outlier Detection 
 Given the high rate of mutations in S. cerevisiae transformants, we expect 5-6% of the colonies to 
contain mutations that could affect gene expression. The CREs and the BCs are sequenced and matched 
before inserting the basal promoter and YFP gene, and before the transformation into S. cerevisiae; 
therefore we do not detect mutations in subsequent steps. CREs represented by 3 or more BCs are not 
affected by this problem, since outlier detection is an easy task in these cases. However, our library 
contains 1806 CREs associated either with one BC only, or with multiple BCs and high variance in 
expression (CV>0.5). Replicate experiments showed that 95% of the CREs represented by only one BC 
produce an accurate measure of gene expression. Instead of eliminating all the CREs represented by a 
low number of BCs, we used the thermodynamic model in a recursive way to identify the true outliers.  
 The first step was to apply the thermodynamic model only to the 827 CREs represented by 2 or 
more BCs, and characterized by low expression variance (CV<0.5). The fit model was used to calculate 
the error for each of the excluded 1806 CREs. The excluded CREs were ranked based on the error and 
reintroduced to the model one at the time until the overall R2 dropped 10% with respect to the original 
model.  This resulted in the exclusion of about 100 CREs. Then the thermodynamic model was applied 
only to the selected CREs. The CREs excluded from our analysis represent the ones whose expression 
cannot be explained by the model. There could be two reasons for this: 1) they contain high 
measurement error, or 2) they contain a specific feature not included in the model. To test whether these 
CREs contain features that we were not capturing with our model, we looked at the sequence contents of 
these excluded CRE: they were not enriched in length (number of building blocks), they were not 
enriched in any specific TFBS, or in any pair of TFBSs. We also tested several models: we added 
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parameters to include 4 or 6 TFs, and to capture the Gcr1-Gcr1 and the Gcr1-Rap1 sites interactions. 
Each time we repeated this recursive procedure, excluding between 96 and 115 CREs, and found no 
common sequence feature in the excluded sets. Moreover, the pairwise intersections of the excluded sets 
were always between 96% and 100%, indicating a small, reproducible set of outliers. After these analyses 
we concluded that the unexplained expression for these outlier promoters must be due either to 
sequencing errors, or to secondary mutations that occurred during their transformation into S. cerevisiae. 
We excluded these outliers from our final analysis, obtaining a final set of 2534 CREs.  
 
PWM Analysis 
 PWM models for TF binding (MacIsaac et al. 2006; Pachkov et al. 2007; Foat et al. 2008; Spivak 
and Stormo 2012) were used to estimate the affinity of TFs to their cognate TFBSs. We used patser 
(Stormo et al. 1982) to calculate these scores. The PWM scores are proportional to the –DG of the 
interaction.  
  
75 
FIGURE A1.1 
 
 
Figure A1.1 Schematic of the CRE-seq method adapted for this study. A) Double stranded 
oligonucleotides encoding TFBS are mixed in a pool and ligated randomly to create a CRE library. B) 
After cloning CRE and BC sequences into a reporter plasmid, the concordance between CREs and BCs 
is determined with a paired-end next generation sequencing run. Each BC identifies a single CRE. C) The 
cassette containing the library of CREs upstream of a basal promoter driving YFP and BC is integrated 
into the S. cerevisiae genome at the TRP1 locus by selecting for URA+ cells. D) Cells are grown in liquid 
culture, and gDNA and RNA is harvested. The fraction of reads in the cDNA pool divided by the fraction 
of reads in the gDNA pool for each BC is a quantitative measurement of the expression driven by the 
corresponding CRE.  
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FIGURE A1.2 
 
 
Figure A1.2 CRE-seq accurately measures gene expression.  A) Comparison between expression 
measured by CRE-seq and flow cytometry. Each dot represents a CRE whose activity has been 
measured with a traditional fluorescent assay (y-axis) and with CRE-seq (x-axis). The high correlation 
indicates that CRE-seq expression measurements are as accurate as those measured by traditional 
fluorescent assay. The red line represents the perfect model (r=1). B) Biological replicates of a CRE-seq 
library where expression is controlled by one CRE matched to 602 different BCs. The library was grown 
and harvested two times; CRE-seq was performed independently on each replicate. Replicate 
measurements of BC expression are plotted on the x-axis (replicate 1) and on the y-axis (replicate 2). The 
absence of correlation reveals that the BCs have no reproducible effects on gene expression.  
  
77 
FIGURE A1.3 
 
 
Figure A1.3 The thermodynamic model consists of a set of interactions that govern TF-DNA and 
TF-TF binding. Each arrow represents an interaction included in the model in the form of a parameter 
proportional to the DG. Black arrows represent the free parameters. A) The set of interactions allowed in 
the simplest model: each TF is allowed to bind to its cognate TFBSs, and to interact with polymerase. 
Mig1 is allowed to interact with itself when two or more Mig1 sites are present in the same promoter. B) 
The set of interactions applied to the model with the highest score: a protein X other than Reb1 is allowed 
to bind at site Reb13, and a protein Y other than Rap1 is allowed to bind at site Rap12. Both Mig1 and 
Gcr1 are allowed to interact with themselves when two or more of their sites are present in the same 
promoter.   
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FIGURE A1.4 
 
Figure A1.4 A) Several model structures with different sets of rules have been applied to the data. Each 
dot represents a specific model, whose score is on the y-axis. The score is plotted as the absolute value 
of the AIC score, calculated taking into account the RSS and a penalty term for the number of free 
parameters (Methods). An increase in the plotted score (thus a decrease in the AIC score) indicates a 
better model. Increasing the number of TFs included in the model from 4 to 6 increases the score. The 
addition of the Gcr1-Gcr1 (GG) interaction always results in a better score. The addition of the Gcr1-Rap1 
(GP) interaction always results in a worse score. The model with the best score is the one with 6 TFs and 
the Gcr1-Gcr1 interaction. All model represented in this plot include the Mig1-Mig1 interaction.  B) The 
thermodynamic model with 6TFs and Gcr1-Gcr1 interaction accurately predicts synthetic promoter gene 
expression. Each dot represents expression driven by one of the 2534 CREs we assayed in this study. 
The measured CRE-seq expression is on the x-axis, while the predicted expression from the 
thermodynamic model is shown on the y-axis. R2=0.57 shows that our model explains 57% of the 
variance in the data. The red line represents the perfect model (R2=1). 
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FIGURE A1.5 
 
 
Figure A1.5 Gcr1 binding sites have complex effects on expression.  A) When Gcr11 sites are added 
to promoters containing only Reb11 or Rap11 TFBSs, their effect is to increase the activation of gene 
expression.  However, when Gcr11 sites are added to promoters containing only Mig11 sites their effect 
on gene expression is repressive. B) Gcr11 TFBS has a weaker repressive effect when added to low 
affinity Mig1 sites (Mig12 and Mig13). C) Gcr1 TFBS with low affinity (Gcr13 and Gcr12) have weak 
repressive interactions when combined with high affinity Mig1 sites (Mig11). 
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TABLE A1.1 
TFBS Sequence Promoter MacIsaac PWM score 
Mig11 CCCCGGATTT SUC2 10.4 
Mig12 CCCCACAAAT MAL61 9.82 
Mig13 CCCCAGGTAT GAL3 6.69 
Reb11 TTACCCGT TPI 8.68 
Reb12 TCACCCGT TRPI 6.15 
Reb13 CAGCCCTT GALI -3.11 
Rap11 ACACCTGGACAT TPI 7.66 
Rap12 ACCCCTTTTTAC TPI -3 
Rap13 ACACCCAAGCAT TPFI 9.95 
Gcr11 CAGCTTCCT TPI 2.88 
Gcr12 CGGCATCCA TPI 7.7 
Gcr13 CGACTTCCT ADH1 8.76 
 
Table A1.1 Summary of binding sites used in this study. This table reports the 12 TFBS sequences in 
our library, including S. cerevisiae promoters where they are present and the PWM score (MacIsaac et al. 
2006). 
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TABLE A1.2 
TFBS A TFBS B PWM DGB - DGA Thermodynamic model DGB - DGA 
Mig11 Mig12 0.58 1.10 ± 0.12 
Mig11 Mig13 3.71 4.40 ± 1.88 
Rap11 Rap13 -2.29 -1.52 ± 0.51 
Reb11 Reb12 2.53 -0.14 ± 0.11 
Gcr11 Gcr12 -4.82 -0.86 ± 0.24 
Gcr11 Gcr13 -5.88 -0.37 ± 0.30 
 
Table A1.2 Comparison between TFBS affinities predicted by thermodynamic modeling and PWM 
analysis. For each combination of variant binding sites (columns 1 and 2), we show PWM predicted 
relative affinities (column 3) and thermodynamic modeled relative affinities (column 4). Each numeric 
value represents the change in DG for the variant in the second column with respect to the variant in the 
first column (DDG). A positive number predicts that site B has a weaker affinity than site A, while a 
negative number predicts site B has a stronger affinity than site A.  
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SUPPLEMENTARY FIGURES AND TABLES 
 
TABLE A1.S1 
 
Parameter Values ±95% CI 
DGMig1-RNAP 3.76±1.95 
DGMig1(R)-RNAP 3.95±2.68 
DGReb1-RNAP -0.14±0.08 
DGReb1(R)-RNAP -0.05±0.11 
DGRap1-RNAP -0.35±0.11 
DGRap1(R)-RNAP -0.21±0.11 
DGGcr1-RNAP -0.27±0.10 
DGGcr1(R)-RNAP -0.37±0.08 
DGX-RNAP -0.24±0.08 
DGX(R)-RNAP -0.13±0.07 
DGY-RNAP -0.18±0.06 
DGY(R)-RNAP -0.20±0.06 
DGMig1-Mig1 -0.68±0.33 
DGGcr1-Gcr1 -0.15±0.12 
DGMig12-DNA - DGMig11-DNA 1.10 ± 0.12 
DGMig13-DNA - DGMig11-DNA 4.40 ± 1.88 
DGRap13-DNA - DGRap11-DNA -1.52 ± 0.51 
DGReb12-DNA - DGReb11-DNA -0.14 ± 0.11 
DGGcr12-DNA - DGGcr11-DNA -0.86 ± 0.24 
DGGcr13-DNA - DGGcr11-DNA -0.37 ± 0.30 
R2 0.57 
 
Table A1.S1 This table reports the estimated parameters of our thermodynamic model as proportional to 
DG or the difference of DGs (DDG). X and Y denote the unknown TFs predicted to bind at site Reb13 and 
Rap12 respectively. (R) denotes the TFBS in the reverse orientation. A negative value for DG between TF 
and RNAP or TF-TF indicates a favorable interaction, while a positive value indicates an unfavorable 
interaction.  A negative value for the difference of DGs between TF and DNA indicates a stronger site 
(higher affinity), while a positive value indicates a weaker site (lower affinity).  
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TABLE A1.S2 
 
Primer 
name 
Sequence 
prIM01 GGCCGAANNNNWNNNNWNNNNNAGCTCGT 
prIM02 CTAGACGAGCTNNNNNWNNNNWNNNNTTC 
prIM03 TATAGGTACCGGCTCGGGTTGGCAAA 
prIM04 GTTCCGGCCGTTATTTGTACAATTCATCCATACCATGGGT 
prIM05 TGAATTGTACAAATAAGCGGCCGAA 
prIM06 TTAACTCGAGAAGTAGATAAAGTCAGTGCTTAAACAC 
prIM07 ATATCTCGAGCCTGCGATGTATATTTTCCTGTAC 
prIM08 CAAGCAGAAGACGGCATACGAGCTCTTCCGATCT 
prIM09 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT 
 
Table A1.S2 Primer sequences used in this study.  
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FIGURE A1.S1 
 
 
Figure A1.S1 The complete CRE-seq cloning strategy with chromosomal integration. First, we 
cloned the CREs into a plasmid creating a library of CRE sequences.  Into this library we then cloned a 
library of BCs downstream of the CREs. To match CREs to BCs we digested away the plasmid 
backbone, ligated Illumina adapters, and sequenced the DNA with a paired end run. We then inserted the 
basal promoter and YFP gene between the CREs and the BCs. Finally, we integrated the library cassette 
into S. cerevisiae at the TRP1 locus, and pooled colonies for use in the CRE-seq assay.  
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FIGURE A1.S2 
 
 
Figure A1.S2 Distribution of BC number per CRE. 66.7% of the CREs are represented by 1 BC only, 
and 16.1% of the CREs are represented by 3 or more BCs. 
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FIGURE A1.S3 
 
 
Figure A1.S3 The effect of 0, 1 and 2 Gcr1, Reb1 and Rap1 sites on gene expression. While 
expression (y-axis) grows linearly with the number of Reb1 and Rap1 sites (x-axis, panels B and C), Gcr1 
shows a different behavior (panel A). We observe no increase over basal expression until two Gcr1 sites 
are present. This plot includes all promoters containing 0, 1, or 2 sites of interest, among other sites. 
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FIGURE A1.S4 
 
 
Figure A1.S4 Expression of promoters composed of the same TFBSs. The expression driven by 
CREs containing adjacent Gcr11 and Mig11 sites (y-axis), is, in general, lower than the expression driven 
by CREs with the same TFBS content but non-adjacent Gcr11 and Mig11 TFBSs (x-axis).  
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FIGURE A1.S5 
 
 
Figure A1.S5 Repeated random sub-sampling validation results. The 2534 data points were split in 
two sets, a training set and a validation set. The size of the training set varied; sets were defined by 
randomly picking 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80% or 90% of the total number of 
data points. The model was fit on the training set and then applied to the validation sets. R2 values were 
estimated for the two sets. The R2 values reported in the first panel of the figure are averaged across the 
20 trials of this procedure. The figure shows that with 1000 unique data points (CREs), we have similar 
performances in the training set as in the validation set. With fewer data points the model is over-fit and 
predicts the validation set less well. The second panel shows that the number of significant parameters 
increases with the number of data points. When we include fewer than 2000 promoters we lose significant 
parameters, while the values of the others do not change significantly. This suggests that in order to 
recover weak behaviors we need to have a large number of unique promoters.  
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ABSTRACT 
The histone modification state of genomic regions is hypothesized to reflect the regulatory activity 
of the underlying genomic DNA. Based on this hypothesis, the ENCODE consortium measured the status 
of multiple histone modifications across the genome in several cell types and used this data to segment 
the genome into regions with different predicted regulatory activities (Dunham et al. 2012; Hoffman et al. 
2013). We measured the cis-regulatory activity of more than 2000 of these predictions in the K562 
leukemia cell line. We tested genomic segments predicted to be Enhancers, Weak Enhancers, or 
Repressed elements in K562 cells, along with other sequences predicted to be Enhancers specific to the 
H1 human embryonic stem cell (H1-hESC) line. Regions annotated as Repressed in K562 cells and 
Enhancer elements in H1-hESC did not show cis-regulatory activity in K562 cells greater than that 
produced by negative controls. In contrast, both Enhancer and Weak Enhancer sequences in K562 cells 
were more active than negative controls, although surprisingly, Weak Enhancer segmentations drove 
higher expression than Enhancer segmentations. Lower levels of the covalent histone modifications 
H3K36me3 and H3K27ac, thought to mark active enhancers and transcribed gene bodies, associate with 
higher expression and partly explain the higher activity of Weak Enhancers over Enhancer predictions, 
suggesting that our understanding of these particular modifications is incomplete.  While DNase 
hypersensitivity (HS) is a good predictor of active sequences in our assay, transcription factor (TF) 
binding models need to be included in order to accurately identify highly expressed sequences. Overall 
our results support the notion that histone modification states reflect the cis-regulatory activity of 
sequences across the genome, but also suggest that specific sequence preferences such as transcription 
factor binding sites are the causal determinants of cis-regulatory activity.  
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INTRODUCTION 
It is widely reported that specific combinations of covalent histone modifications reflect the 
regulatory function of underlying genomic DNA sequence (Strahl and Allis 2000). As part of the ENCODE 
project the genomic locations of a variety of covalent histone modifications were determined by chromatin 
immunoprecipitation sequencing (ChIP-seq) in a number of cell types and cell lines. Two studies used 
these data to train computational models that predict different functional regions of the human genome. 
These unsupervised learning algorithms, Segway (Hoffman et al. 2012) and ChromHMM (Ernst and Kellis 
2010; Ernst and Kellis 2012), take functional genomics data as input (DNase-seq; FAIRE-seq; and ChIP-
seq of histone modifications, RNA Polymerase II, and CTCF) and return segmentation classes, which are 
then assigned a hypothesized function using current knowledge of histone modification function. As part 
of the ENCODE project, these two sets of predictions were consolidated to create a unified annotation of 
the entire human genome with seven functional classes in multiple cell types. These segmentations 
include Transcription Start Site, Promoter Flanking, Transcribed, CTCF-bound, Enhancer, Weak 
Enhancer, and Repressed or Inactive segments (Dunham et al. 2012; Hoffman et al. 2013). If histone 
modifications accurately reflect the regulatory activity of their associated DNA, then these segmentation 
classes should have measurably different cis-regulatory activities.  
In this study we tested whether the segmentation classes determined by ENCODE have different 
effects on gene regulation in their predicted cell type. We used CRE-seq, a massively parallel reporter 
assay, to determine whether 1) sequences in the Enhancer, Weak Enhancer and Repressed classes 
drive expression that is different from that produced by negative controls, 2) sequences in different 
segmentation classes drive different levels of gene expression, and 3) sequences control gene 
expression level consistent with their predicted segmentation labels. We find that segmentation 
predictions drive distinct levels of expression.  In particular, enhancer predictions drive expression that is 
different than the expression levels driven by negative control sequences.  We find that chromatin 
features can distinguish highly expressed sequences with some accuracy, but transcription factor binding 
preferences better identify the most highly expressed sequences.  
 
RESULTS 
92 
 
CRE-seq Library and Measurements 
We used a high-throughput multiplexed reporter assay (Kwasnieski et al. 2012; Melnikov et al. 
2012; Patwardhan et al. 2012) to characterize the regulatory activity of 2100 randomly chosen sequences 
annotated as Enhancer, Weak Enhancer, or Repressed. Specifically, we tested sequences with the 
following annotations in the K562 cell line: 600 Enhancer regions, 600 Weak Enhancer regions, and 300 
Repressed regions. In order to test the cell-type specificity of the segmentation predictions, we also 
tested 600 Enhancer predictions from the H1-hESC cell line that are not annotated as Weak Enhancers 
or Enhancers in K562 cells. 
We sought to establish an empirical null distribution as a negative control for activity in this assay, 
against which to compare the activities of sequences from the different segmentation classes. We 
randomly selected 284 sequences from each class of predictions and scrambled the nucleotide sequence 
of each while maintaining dinucleotide content, in order to preserve basic sequence features of the 
segment such as CpG frequency and nucleosome favoring signals. We designed our experiment to 
compare the expression distribution for each segmentation class to the expression distributions from their 
corresponding scrambled negative controls. Including predicted cis-regulatory elements (CREs) and 
scrambled negative controls, our final experimental design included 3237 distinct reporter gene 
constructs.  
We used CRE-seq, a massively parallel reporter gene assay (Kwasnieski et al. 2012) to 
simultaneously measure the expression of all constructs. We first synthesized 13,000 unique 200-mer 
DNA sequences using array-based oligonucleotide (oligo) synthesis (LeProust et al. 2010). Each 
predicted CRE was replicated four times on the array, and each replicate was tagged with a unique nine 
basepair (bp) barcode, providing redundancy in the expression measurements. The 200 bp limit of 
oligonucleotide synthesis, along with the requirement to include priming sites and restriction enzyme sites, 
limited our tested CREs to 130 bp of each segmentation prediction. For the Enhancer and Weak 
Enhancer classes, we selected the entire region of 300 short (121-130 bp) genomic segments, and the 
central 130 bp of 300 longer genomic segments (>130 bp). As only a small fraction of Repressed 
segments are less than 130 bp in length, we tested only central sequences from this class. We chose the 
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center because it is an unbiased portion that does not incorporate additional histone or sequence features 
beyond the algorithms’ output. This allows us to appropriately test the predictive power of the 
segmentations. Finally, we used the array-synthesized oligos to create a library of these CREs cloned 
upstream of the Hsp68 minimal promoter in which each reporter construct contains a unique sequence 
barcode in its 3’ UTR (Kwasnieski et al. 2012). The resulting plasmid library was then transfected into 
K562 cells, and RNA was isolated after 22 hours.  
To measure CRE activity, we quantified the level of each barcode in the transfected cells using 
RNA-seq, and normalized the RNA barcode counts by the abundance of each barcode in the plasmid 
DNA pool. The RNA/DNA ratio of barcode counts is a quantitative measure of the expression driven by 
each CRE in the library (Kwasnieski et al. 2012). We performed four independent transfections in K562 
cells and found that our expression measurements are precise, displaying high reproducibility between 
biological replicates (Figure A2.1A, R2 range: 0.95-0.97). 
 
Expression of Segmentation Classes 
We compared the activity of each class of segmentation prediction to the activity controlled by its 
matched scrambled distribution. We used two independent metrics to classify individual segmentations as 
“active” or “inactive”. First, we computed the fraction of CREs within a segmentation class that drive 
expression higher than that of the 95th percentile of the matched scrambled expression distribution. 
Second, for each CRE we compared its sixteen replicate measurements (four barcodes per CRE in four 
independent experiments) with the distribution of the scrambled controls (Wilcoxon Rank Sum Test, 
p<0.05, Bonferroni correction with N=2100). Using these metrics, a significant number of Enhancer and 
Weak Enhancer CRE predictions are active (Figure A2.1B, A2.1C, Table A2.1). In contrast, neither the 
K562 Repressed regions nor the H1-hESC Enhancer regions show activity that is significantly different 
from their scrambled negative controls (Figure A2.1D, A2.1E, Table A2.1). Enhancer and Weak Enhancer 
regions show distinct levels of activity from both the K562 Repressed and H1-hESC Enhancer regions 
(Wilcoxon Rank Sum, P<0.01).  Moreover, segmentations from the Repressed category did not repress 
expression below the 5th percentile of their matched scrambled controls, suggesting that these sequences 
are transcriptionally inactive and not repressive. We get the same results regardless of whether the 
94 
sequences are short segmentations included in their entirety, or longer predictions from which we 
included only the central 130 bp (Supplemental Figure A2.S1), indicating that our results are not biased 
by the method of choosing 130 bp sequences for testing. Taken together, we conclude that sequences 
annotated as Enhancer and Weak Enhancer segments have increased levels of activity over their 
corresponding null distributions, and that different segmentation classes produce distinct median levels of 
activity in our assay.  
Unexpectedly, we found that sequences classified as Weak Enhancers drive a higher median 
level of activity than sequences classified as Enhancers (Supplemental Figure A2.S2, P=3.7e-4 by 
Wilcoxon Rank Sum). The difference between the two classes is even greater when comparing the 
fraction of CREs we designated as “active” relative to their matched scrambled sequences. (Table A2.1). 
Compared to Weak Enhancers, segmentations in the Enhancer class have higher GC content 
(Supplementary Figure A2.S3B), a sequence feature associated with higher cis-regulatory activity 
(Landolin et al. 2010; Lidor Nili et al. 2010; White et al. 2013).  Indeed scrambled sequences derived from 
the Enhancer class drive higher expression than scrambled sequences from the Weak Enhancer class 
(Supplementary Figure A2.S3A). Therefore, despite having higher GC content, a feature associated with 
higher expression, the Enhancer predictions drive lower expression than the Weak Enhancer predictions. 
This suggests that some additional determinant is responsible for the higher activation of segments 
labeled as Weak Enhancers. 
We asked whether differences in covalent histone modifications might explain the difference in 
expression between Weak Enhancers and Enhancers. We compared the levels of all histone 
modifications (Hoffman et al. 2013) that were measured in K562 cells between the two classes. Weak 
Enhancers were segmented from Enhancers by their lower levels of the histone modification H3K27ac 
(Creyghton et al. 2010) (Figure A2.2B), thought to signify active enhancers, and H3K36me3 (Barski et al. 
2007) (Figure A2.2D), often thought to signify a transcribed gene body but recently also found in silenced 
genes (Chantalat et al. 2011). Surprisingly, lower levels of both of these covalent histone modifications 
are associated with higher expression of enhancers in our assay (Wilcoxon Rank Sum Test, p<10-5, 
Figure A2.2A, A2.2C), even within the Enhancer or Weak Enhancer classes (Supplemental Figure A2.S4). 
We did not find an association of H3K27ac signal in the larger context (up to 500bp surrounding the 
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selected regions) or H3K27ac dip score with active enhancers (Kheradpour et al. 2013) (data not shown). 
Thus, Weak Enhancers may have more activity than Enhancers in part because they have lower 
enrichment of H3K27ac and H3K36me3, which associate with higher activity in our assay. These histone 
modifications do not fully explain the expression differences between these two classes indicating that 
other sequence features must explain the higher activity of Weak Enhancers. 
 
Sequence and Chromatin Features 
We searched for sequence and chromatin features that could predict activity across all 
segmentation classes in our assay. Two primary sequence features (GC content and minor groove width 
as estimated by ORChID2 (Rohs et al. 2009; Bishop et al. 2011) score) and six chromatin features 
(Dunham et al. 2012; Hoffman et al. 2013) (DNase HS from Duke; DNase HS from University of 
Washington [UW]; Faire-seq; and ChIP-seq of H3K4me1, H3K36me3, and RNA Pol2) are significantly 
enriched in sequences that drive high expression in our assay (Wilcoxon Rank Sum test, P<0.05 
corrected with Bonferroni method, N=16). We used these data to develop a quantitative model that 
distinguishes active CREs from inactive CREs. Of these eight features, DNase HS (UW) signal best 
separated the active from inactive sequences (Figure A2.3A, A2.3B, AUC=0.685), suggesting that DNA 
accessibility is a good indicator of the cis-regulatory potential of a sequence (Thurman et al. 2012). No 
other single feature performed as well as DNase HS signal. A logistic regression model with the above-
mentioned six chromatin features and two primary sequence features (PSF), improves the classification 
of active sequences (Figure A2.3A, AUC=0.733), but only marginally above that of DNase HS alone. We 
therefore hypothesized that additional sequence-specific binding features, such transcription factor 
binding motifs, may better explain expression.  
We investigated whether the inclusion of transcription factor (TF) binding specificities improved 
our ability to explain the expression differences we observed in our assay. Using several libraries of TF 
binding models (Newburger and Bulyk 2009; Jolma et al. 2013; Mathelier et al. 2013), we searched for 
motifs enriched or depleted in activated CREs and found 50 significant, non-redundant motifs. A logistic 
regression model that incorporated these binding models performs better at distinguishing active 
sequences than the chromatin and PSF model (Figure A2.3A, AIC (Akaike 1974): 1881 vs. 1729 for 
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model with motifs; AUC=0.802). We performed 5-fold cross-validation on all of the models and observed 
little decrease in predictive power, suggesting that our model is not over-fit (Supplemental Table A2.S2). 
The predicted motif for Activator Protein 1 (AP1), a heterodimer of TFs in the FOS and JUN families(Hess 
et al. 2004), is the most significantly enriched motif in highly expressed CREs. The expression driven by 
CREs with predicted AP1 motifs is significantly higher than the expression driven by sequences without 
the motif (Figure A2.3C, log2 ratio of 0.96, p<2.2x10-16). Furthermore, highly expressing CREs are 
significantly enriched for sequences that are bound by FOS and JUN family TFs in K562 cells 
(Consortium 2011). (Figure A2.3D; p=8.8x10-10 by Fisher’s exact test, odds ratio=4.2). These data 
suggest that AP1 is responsible for the activity of many enhancers in K562 cells, as previously reported 
(Muthukrishnan and Skalnik 2009; Kheradpour et al. 2013), and, as a consequence, the enhancers’ 
histone modification state.   
DISCUSSION  
In this study we directly tested the cis-regulatory activity of segmentation predictions based on 
histone modification data from the ENCODE project. We found that these predictions were cell type-
specific in K562 cells and could accurately distinguish enhancer sequences from non-enhancer 
sequences. Our results suggest that combinations of TF binding preferences, not histone modifications 
alone, are most predictive of actively expressing genomic sequences, a result supported by other 
attempts to define the sequence features of enhancers (Heinz et al. 2010; Lee et al. 2011; Arvey et al. 
2012; Gorkin et al. 2012; Smith et al. 2013). These results support a model where TF binding and 
subsequent transcriptional regulation configure the immediate chromatin environment (Struhl and Segal 
2013), leading to the constellation of histone modifications observed in segments with high cis-regulatory 
activity. However, even our model incorporating all of the available features is only moderately predictive 
(AUC=0.84) and cannot quantitatively predict expression level. This suggests that more complex features 
determine the quantitative expression levels controlled by enhancers.  
We conclude that the Repressed segmentation class consists mostly of sequences with no 
transcriptional activity rather than cis-regulatory sequences that actively repress transcription. We have 
previously shown transcriptional repression by short enhancers (White et al. 2013), indicating that the 
length of CREs we tested cannot explain this result. There are two possible explanations for why we did 
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not see repression in this assay. First, the Repressed segmentation class contains mostly sequences with 
predicted low activity by either the ChromHMM or Segway algorithms, with only a small fraction of the 
sequences predicted to have repressive activity by these algorithms. Second, it is possible that we are 
unable to predict combinations of histone modifications that signal repression such that no segmentation 
successfully defines repressive activity. Because a large fraction of regulated gene expression works 
through the activity of transcriptional repressors, identifying combinations of histone modifications that 
reflect repression is still an important challenge. 
Finally, we conclude that combinations of histone modifications identify functional enhancers, but 
our interpretation of these combinations needs to be refined. In particular, high levels of the covalent 
histone modifications H3K27ac and H3K36me3 are thought to mark active enhancers and transcribed 
gene bodies or even heterochromatic regions (Barski et al. 2007; Creyghton et al. 2010; Chantalat et al. 
2011). Among segments marked as Enhancers or Weak Enhancers, lower enrichment of these 
modifications is found at segments with high activity in this assay. This finding suggests that the precise 
function of these modifications needs to be explored, as it is clear that there is no simple linear 
relationship between the level of these modifications and expression.  
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MATERIALS AND METHODS 
 
CRE-seq Library Construction 
A pool of 13,000 unique 200-mer oligos was ordered through a limited licensing agreement with 
Agilent Technologies. Oligos were structured as follows: 5’ priming sequence (GTAGCATCTGTCC)/NheI 
site/CRE/HindIII site/XhoI site/SphI site/ barcode/SacI site/3’ priming sequence (CGACTACTACTACG). A 
more detailed diagram of array sequence is provided in Supplemental Figure A2.5. 
The plasmid library was prepared as described (Kwasnieski et al. 2012), except using primers 
CF166 and CF167 (Supplemental Table 1) and an annealing temperature of 57C. The amplified library 
product was purified on a polyacrylamide gel as described (White et al. 2013). The library plasmid 
backbone, CF10, was created from the plasmid pGL4.23, by cloning dsRed-Express2 between the 
Acc65I and FseI sites. Purified library amplicons were cloned into CF10 using NheI and SacI. We 
prepared DNA from 100,000 colonies to generate PL7_1. We then cloned the Hsp68 promoter driving 
DsRed into PL7_1. A cassette containing the Hsp68 promoter was amplified from pGL-hsp68 with 
primers CF121 and CF168 (Supplemental Table 1). pGL-hsp68 was created by amplifying the hsp68 
promoter from hsp68LacZ (kind gift of M. de Bruijn, Oxford Stem Cell Institute, Oxford, UK) using primers 
JKO25F and JKO25R (Supplemental Table 1). The hsp68 DsRed amplicon was cloned into library PL7_1 
by using HindIII and SphI, creating library PL7_2. 
 
Cell culture and Transfection 
K562 cells were maintained in Iscove's Modified Dulbecco's Medium (IMDM) medium with 10% 
Fetal Bovine Serum and 1% Amino Acids (Life technologies). The plasmid library was purified by phenol-
chloroform extraction and ethanol precipitation before transfection. The Neon transfection system (Life 
technologies) was used to transfect the plasmid library. For each replicate, 1.2 million cells were pelleted 
by centrifugation, washed with PBS and resuspended in 100µl of Buffer R. 27µg plasmid library DNA 
along with 3 µg of pMax-GFP as a positive control was transfected into the cells by using three 10ms 
pulses at 1450V. The transfected cells were seeded into T-25 flasks with 5ml of the growth medium and 
incubated at standard conditions. Transfection efficiency was greater than 90% (data not shown). 
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Selection of Segmentation Predictions  
 Segmentation predictions (Dunham et al. 2012; Hoffman et al. 2013) were downloaded from the 
ENSEMBL genome browser and converted to UCSC notation. We filtered predictions that overlapped 
with the ENCODE DAC Blacklisted Regions (http://moma.ki.au.dk/genome-mirror/cgi-
bin/hgFileUi?db=hg19&g=wgEncodeMapability) or Repeat Masker regions 
(http://www.repeatmasker.org/species/homSap.html).  
We also removed predictions that contained restrictions site sequences that we intended to use 
for cloning sequences into a plasmid library. To select H1-hESC Enhancer predictions, we removed H1-
hESC Enhancer predictions that overlapped with K562 Enhancer or Weak Enhancer predictions. Next we 
sorted predictions by chromosome, and separated them by length into long (>130 bp) and short (121-130 
bp). To choose the predictions to test, we selected lines of this file at regular intervals, so the tested 
CREs span all chromosomes of the human genome.  
 
Preparing Samples for RNA-Seq 
RNA was extracted from K562 cells 22 hours after transfection using the PureLink RNA mini kit 
(Life Technologies) and then excess DNA was removed using the TURBO DNA-free kit (Applied 
Biosystems), following manufacturer’s instructions. First strand cDNA was synthesized from the RNA 
using SuperScript II Reverse Transcriptase (Life Technologies). Both the cDNA samples and the DNA 
from the original plasmid library were prepared for sequencing using a custom protocol as 
described(Kwasnieski et al. 2012). Briefly, we used PCR amplification of the sequence surrounding the 
barcode in the RNA transcript or plasmid using primers CF150 and CF151b (Supplemental Table 1). We 
then digested the PCR product using SphI and XhoI and ligated Illumina adapter sequences (MO576/582, 
MO577/583, MO578/584, MO579/585, Supplemental Table 1) to these amplified sequences. Two lanes 
of the Illumina HiSeq machine were used to sequence this barcode region from the cDNA and DNA, and 
reads that perfectly matched the first 13 expected nucleotides were counted, regardless of quality score. 
This resulted in 77.5 million reads from the cDNA, across 4 biological replicates, and 34.8 million reads 
from the DNA. Only barcodes with >=50 reads in the DNA pool and >=3 reads in the cDNA pool were 
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used for downstream analysis. The expression of each barcode was calculated as (cDNA reads)/(DNA 
reads) and then normalized to the expression of the basal promoter alone. The expression of each CRE 
was calculated as the mean of the expression of each BC associated with it. 
 
Data sources 
We used the normalized chromatin ChIP-seq, Faire-seq, and DNase-seq data used in the 
integrated segmentation of the genome by Hoffman et al. (Hoffman et al. 2013), which can be accessed 
at https://sites.google.com/site/anshulkundaje/projects/wiggler. These included (all from K562 cell line): 
CTCF, Duke DNase, UW DNase, Faire, H3K27ac, H3K27me3, H3K36me3, H3K4me1, H3K4me2, 
H3K4me3, H3K9ac, H4K20me1, Pol2, and Control. This data was produced by the ENCODE consortium 
(Dunham et al. 2012). The signal associated with each CRE we analyzed was the average signal over 
that segment. 
The TF binding matrices were taken from three databases: JASPAR vertebrate (146 matrices) 
(Mathelier et al. 2013), uniPROBE (757 matrices) (Newburger and Bulyk 2009), and high-throughput 
SELEX (820 matrices) (Jolma et al. 2013). FIMO (Grant et al. 2011) was used to find binding sites in the 
CREs used in the assay (both genomic and scrambled), using the default options with a p-value threshold 
of 10-4. The AP-1 binding matrix that was enriched in highly expressed sequences in our assay was from 
JASPAR (MA0099.2). 
TF ChIP-seq data was obtained from 
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeRegTfbsClustered/. 
GC-content and ORChID2 (Rohs et al. 2009; Bishop et al. 2011) scores were calculated from the 
nucleotide sequences of the CREs.  
 
Logistic regression models 
A logistic regression model was developed to predict sequences activated over the scrambled 
90th percentile. The parameters for the model were chosen from a filtered list of available genomic data 
and sequence features. Each of the three sets of parameters was filtered separately: histone data 
including primary sequence features (GC-content and ORChID2 scores), binding matrices, and a set of 
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peaks from TF ChIP-seq. Those scores that had a significantly different distribution of values in the active 
CREs (expression greater than the 90th percentile of the matched scrambled distribution) vs. the inactive 
CREs passed the filter. For the parameter set with histone data and primary sequence features (PSF) 
and the parameter set with binding matrices we used Wilcoxon rank sum test (p<0.05, corrected using 
Bonferroni with N=16 for histone and N=1687 for binding matrices). For the TF ChIP-seq peak data 
(which is in binary form) we used Fisher’s exact test (p<0.05, corrected using Bonferroni with N=16). 73 
binding matrices, 8 histone with PSF parameters (including GC-content and ORChID2 scores), and 8 TF 
ChIP-seq parameters passed the filter. The binding matrices were further filtered to remove ones that 
showed nearly identical binding patterns across the CREs (>=99% similar), resulting in 50 binding 
matrices.  
A logistic regression model for predicting actively expressed CREs was created for each of the 
three sets of parameters separately and with all sets of parameters together (66 total parameters). Only 
additive terms were used. We then created receiver operating characteristic (ROC) curves attempting to 
correctly predict the activated CREs (over 90th percentile of the matched scrambled distribution). The area 
under the curve (AUC) was calculated for each model as well as the best performing histone parameter 
(UW DNase), GC-content, and ORChID2 scores. Additionally, five-fold cross validation was used to 
ensure our models were not over-fit. The CREs were split into five training groups, and the model was 
trained on the data holding out each group in turn (beginning with the filtering of the parameters) and 
tested on the group held out. AUC was calculated for each of these sets, and the mean AUC from the five 
sets was calculated (Supplementary Table 2). 
 
  
102 
Figure A2.1 
 
Figure A2.1. Reproducible expression measurements show differences in expression by 
segmentation class. A) Representative scatterplot showing expression of each CRE in two biological 
replicates (R2=0.95, range of R2 between all replicates: 0.95-0.97). Dashed black line is line of equality 
and blue line is best fit. B-E) Histograms of genomic CRE expression measurements in K562 cells. Each 
class is compared to scrambled controls with equivalent GC and dinucleotide content (grey). Dashed 
lines are the 5th and 95th percentiles of the scrambled distributions. B) K562 Enhancer class (blue), C) 
K562 Weak Enhancer class (green), D) K562 Repressed class (red), E) H1-hESC Enhancer class 
(orange). 
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Figure A2.2 
 
Figure A2.2. Lower H3K27ac and H3K36me3 signal are associated with higher Weak Enhancer 
expression. Boxplots showing that A) H3K27ac signal and C) H3K36me3 signal are depleted in active 
CREs compared to inactive CREs. B) H3K27ac signal and D) H3K36me3 signal are also depleted in 
Weak Enhancers (green) compared to Enhancers (blue). Active CREs are those above 95th percentile of 
scrambled distribution (Table 1).  
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Figure A2.3 
 
Figure A2.3. Chromatin features and sequence-specific binding identify active sequences.  
A) Receiver operating characteristic (ROC) curve shows that a logistic regression model (“Model 
comprehensive”) incorporating sequence-specific binding motifs, chromatin features, primary sequence 
features (PSF), and TF ChIP data is best able to identify active sequences. Of logistic regression models 
with fewer features, one with sequence-specific binding motifs (“Model motifs”) does best, followed by a 
model incorporating chromatin and primary sequence features (“Model chromatin and PSF”), a model 
with only significant TF-ChIP features (“Model TF-ChIP”). Minor groove width as predicted by ORChID2 
score, GC content and DNase HS are also shown. Area under the curve (AUC) is indicated in legend. B) 
Boxplot showing that active CREs are enriched in high DNase HS signal over inactive CREs. C) Boxplot 
showing that CREs with at least 1 predicted AP-1 motif drive higher expression than CREs with no AP-1 
predicted motifs. D) CREs overlapping with ChIP-seq peaks for a FOS (FOS or FOSL1) family member 
and a JUN (JUNB or JUND) family member, the constituent proteins of AP-1, drive higher expression 
than unbound CREs. 
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Table A2.1 
Segmentation Prediction Active over 95% scrambled Active by Wilcoxon 
K562 Enhancer 11.3% [5%] 26.8% [13.4%] 
K562 Weak Enhancer 25.7% [5%] 39.7% [15.5%] 
K562 Repressed 5.35% [5%] 7.00% [8.45%] 
H1-hESC Enhancer 4.34% [5%] 12.0% [16.6%] 
 
Table A2.1. Percentage of active CREs by segmentation class. For each ENCODE segmentation 
class, the table shows the percentage of all genomic CREs that are active with the percentage of 
matched scrambled controls that are active in square brackets. Activation was determined by comparing 
CRE expression to the 95th percentile of matched scrambled controls (Active over 95% scrambled) or by 
statistically comparing replicate measurements of expression to matched scrambled control distribution 
(Active by Wilcoxon, Wilcoxon Rank Sum test, P<0.05, corrected using Bonferroni method with N=2100 
for genomic CREs and N=1136 for scrambled control CREs). 
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SUPPLEMENTARY FIGURES AND TABLES 
 
Table A2.S1 
Name Sequence 
Primer CF121 TAGCGTCGAGGACATCAAGA 
Primer CF150 TACACCGTGGTGGAGCAGTA 
Primer CF151b AGCGTACTCGAGTTGTTAACTTGTTTATTGCAGCTT 
Primer CF168 ATGCATGCCTAGAATTACTACTGGAACA 
Primer JKO25F CATCAAGCTTCTCCTCCGGCTCGCT 
Primter JKO25R CGTTGTAAAACGACGGGATC 
Adapter MO576 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC
TCTTCCGATCTGCTCGATCATG 
Adapter MO577 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC
TCTTCCGATCTTAGACTATCATG 
Adapter MO578 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC
TCTTCCGATCTCGCTACCCTCATG 
Adapter MO579 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC
TCTTCCGATCTATAGTGGACACATG 
Adapter MO582 ATCGAGCAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCT
CGGTGGTCGCCGTATCATT 
Adapter MO583 ATAGTCTAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATC
TCGGTGGTCGCCGTATCATT 
Adapter MO584 AGGGTAGCGAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGAT
CTCGGTGGTCGCCGTATCATT 
Adapter MO585 TGTCCACTATAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGA
TCTCGGTGGTCGCCGTATCATT 
 
Supplemental Table A2.S1: Oligonucleotide sequences used in this study. 
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Table A2.S2 
 
Model Num of Parameters AIC AUC CV mean AUC 
Histone and PSF 8 1881.5 0.733 0.722 
TF ChIP 8 2007 0.622 0.5974 
Binding 50 1728.9 0.802 0.758 
Comprehensive 66 1643.3 0.841 0.798 
 
Supplemental Table A2.S2: Logistic Regression Models. The four logistic regression models used to 
predict active CREs from our assay: Histone and primary sequence features (PSF) included histone 
features, GC-content, and ORChID2 score; TF ChIP included peaks from TF ChIP-seq; binding included 
predicted binding models for TFs; and comprehensive included parameters from all of the models. Akaike 
Information Criteria (AIC), area under the curve (AUC) using the full data for training and testing, and the 
mean AUC from 5-fold cross-validation (CV) is listed for each model.  
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Figure A2.S1 
 
Supplementary Figure A2.S1. Computing the fraction of active sequences does not depend on the 
method of choosing short segments. Histograms showing the distribution of expression for each class; 
A) Enhancers (blue), B) Weak Enhancers (green), C) H1-hESC Enhancers (orange); either for the 
sequences from the center of longer segments (“Center”), or from whole short segments (“Short”), 
compared to their matched scrambled controls (grey). The dashed lines indicate the 5th and 95th 
percentiles of the scrambled distribution. The percentage of elements with expression greater than the 
scrambled 95th percentile is indicated. 
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Figure A2.S2 
 
 
Supplementary Figure A2.S2. Weak Enhancers control higher median expression than Enhancers. 
Histogram of expression measurements, showing the distribution of Weak Enhancers (green) shifted to 
the right of that of Enhancers (blue). Lines show median expression for Enhancers (dotted) and Weak 
Enhancers (dashed). 
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Figure A2.S3 
 
Supplementary Figure A2.S3. Expression and GC Fraction of Scrambled CREs. A) Histograms 
showing the expression controlled by each set of scrambled sequences. B) Boxplots show the distribution 
of GC fraction for each category of scrambled sequences.  
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Figure A2.S4 
 
Supplementary Figure A2.S4. Active Weak Enhancer and Enhancer CREs have lower levels of 
H3K36me3 and H3K27ac. Boxplots showing that H3K27ac signal and H3K36me3 signal are depleted in 
active CREs compared to inactive CREs. Plots are similar to 2A and 2C except data is separated by 
segmentation class. Active CREs are those above the 95th percentile of the scrambled distribution (Table 
1).  
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Figure A2.S5 
 
Supplementary Figure A2.S5. Diagram of 200-mer Oligos Used to Construct the CRE-seq Library. 
Red sequences are used for PCR priming and blue sequences are restriction enzyme sites. The CRE is 
the 121-130bp sequence from the genomic predictions or scrambled controls. The FILL is 0-9bp of 
random sequence to bring the length of the whole oligo sequence up to 200bp. The length of the FILL 
sequence is calculated as 130-length of CRE. The BARCODE is a 9bp sequence that will label the 3’ 
UTR of the mRNA transcript. 
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